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 The ability to sample a chemical reaction mixture on-line and on a continuous 
basis can lead to a better understanding of the chemical process, resulting in improved 
yield and quality of product.  This is particularly important for the development of active 
pharmaceutical ingredients (APIs).  Two primary areas of improvement needed for near 
real-time sampling in the pharmaceutical industry are sampling from small-scale 
reactions (several milliliters), such as may be used during research and development, and 
sampling from heterogeneous reactions that contain solid particles.  For small-scale 
reactions, a sampling device that removes microliters of the reaction mixture is required.  
A “push-pull” sampler was constructed from coaxial fused silica capillaries that 
continuously removes sample from a reactor at low flow rates (µL/min) and mixes the 
sample rapidly with a quenchant to preserve the reaction conditions before analysis.  
Finite element analysis showed that reducing the pull capillary ID resulted in faster 
mixing, while flow rate had a minimal effect on mixing time.  This sampler was used 
with samples spanning a range of viscosities (1.5 – 4.8 Pas), and with samples 
containing spherical polystyrene beads 10 – 500 µm in diameter.  The sampler was 
demonstrated by monitoring an aqueous enzymatic reaction as well as an organic 
reaction.  A  “droplet” sampler was then developed that uses segmented flow to remove 
sample from a reactor on demand.  This sampler can remove and run very small (0.1 – 2 
µL) samples with on-demand sampling.  A third device was developed specifically for 
  xiv 
heterogeneous samples that contain solid particles.  This “soup pot” sampler was a 
custom-built borosilicate glass chamber for mixing sample with quenchant and diluent.  
A syringe was used to obtain sample and to mix the sample with quenchant/diluent in the 
chamber.  A Teflon stopcock was modified to allow access to the reactor vessel while 
also providing a leak-free seal during mixing.  The sampler was coupled to an analytical-
scale HPLC and was demonstrated for monitoring dibutyl phthalate hydrolysis.  These 
samplers represent several prototypes for further development of automated process 








 A trend in the pharmaceutical industry is to combine real-time chemical 
measurements with statistical analysis to improve pharmaceutical manufacturing.  These 
techniques, collectively known as Process Analytical Technologies (PAT), are designed 
to ensure timely feedback so the drug manufacturing process may be controlled and 
improved, with the ultimate goal of real-time release of product.1-3 The United States 
Food & Drug Administration (FDA) holds the pharmaceutical industry strictly 
accountable in all aspects of drug product manufacturing, under its mandate to protect 
consumers.  Before they may be released to the market, batches of drug product must be 
assayed to insure they fall within specifications for active pharmaceutical ingredient 
(API) quantity and bioavailability, as well as verifying that levels of impurities fall below 
maximum allowable limits.  The tests required for each drug product are standardized 
across the industry, often through the United States Pharmacopeia (USP).  As it is not 
cost-effective to test every unit (tablet, caplet, etc.) of a batch, only a small portion of the 
final batch undergoes testing.  This assumes that the distribution of properties within a 
batch is Gaussian and that there is minimal variation throughout the batch.1  When this is 
not true, “unit to unit variability causes sampling procedures to become a matter of luck 
as to whether or not the specification is met, thus creating a kind of sampling roulette.  
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This sampling roulette will cause the failure of some batches that are literally the same as 
batches that are released.”1  This method of testing may result in wasted product or in 
product being released to the market that does not meet the required specifications.  
 Variability in the final drug product may result from variability in the raw 
materials, variability in the quality of the intermediates in the synthesis of the API, and 
mixing the API with inactive ingredients to form the final product.  Under a traditional 
production regime, strict process standards are maintained in an effort to control each of 
these possible sources of variability.  For example, temperature and reaction time may be 
very carefully controlled during API synthesis, but without monitoring the progress of the 
reaction itself, small variations in the raw materials may result in large variability in the 
quality of the API.  Monitoring the API synthesis on the time scale of the reaction allows 
for improved understanding of the process (and what factors increase variability within a 
batch) as well as the opportunity to change the reaction conditions to insure the final 
product falls within the necessary parameters. 
 Prior to 2002, there was little incentive for the pharmaceutical industry to 
implement real-time monitoring of API synthesis, because while it might improve their 
understanding of the process, it also added an additional layer of testing to that already 
required by the FDA.  Additionally, it was not clear if they would be held accountable for 
the results of additional testing if those results indicated additional impurities or other 
problems not detected by standard testing.  The FDA has acknowledged that this 
perception that the regulatory environment is “rigid and unfavorable to the introduction 
of innovative systems”2 has been cited as a primary reason that real-time process 
monitoring and control was not receiving more attention within the industry.  
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 This hesitancy toward innovation concerned the FDA.  In 2002, they launched an 
initiative titled, “Pharmaceutical cGMPs for the 21st Century: A Risk-Based Approach,” 
which sought to emphasize real-time understanding and control of drug manufacturing as 
a priority for ensuring a stream of safe, effective and inexpensive drug products2 (cGMPS 
are Current Good Manufacturing Practices).  In 2004 they released “Guidance for 
Industry: PAT — A Framework for Innovative Pharmaceutical Development, 
Manufacturing, and Quality Assurance”, which outlined their support for voluntary 
innovation in the industry.2  Most importantly, the FDA offered support and flexibility, 
allowing the industry to rely on previous testing requirements while developing new 
testing methodology.  While pharmaceutical PAT is still very much in its infancy, PAT is 
becoming more commonplace and the FDA has approved a number of new drug 
applications that implement PAT, rather than traditional methods, for quality control.4  
 In order to control a reaction, testing needs to be performed within the time frame 
of the reaction.  Traditionally, when a reaction is studied, samples are manually removed 
from a reactor, quenched and diluted, and sent to a central analytical laboratory for 
analysis.  Depending on the workload, samples may take hours or days to be processed 
using this method.  When sampling and analysis occur at the source of the process, using 
fast analysis techniques, information gained about the reaction process may be used for 
real-time decision making, changing reaction conditions to insure the desired final 
product is produced.3   
 The focus of this work is on at-line (sample is removed from the process stream 
and analyzed nearby) monitoring of API synthesis, enabling better process understanding 
and control.  APIs may be synthesized biologically or chemically, and each synthesis 
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reaction presents its own challenges for sampling and analysis.  Reactions may vary in 
temperature or viscosity, and may contain particulates such as cell debris or solid 
catalysts that introduce challenges for sample preparation and analysis.  The scale of the 
reaction may also complicate at-line monitoring. At the research stage (pre-
manufacturing), API synthesis reactions range from small-scale (< 10 mL) up to large-
scale (20-30 L).  At the small-scale, very small (µL) sampling volumes must be removed 
to avoid perturbing the reaction.  At the large-scale, interfacing a sampling device with 
the reactor and ensuring that sampling is representative of the bulk reaction is a 
challenge.   
 We focused our sampler development on reaction volumes of < 1 L.  Desired 
performance parameters for at-line sampling of a medium-scale reaction (50-500 mL), as 
defined by a major pharmaceutical company, are given in Table 1-1.  The designed 
device should be capable of removing samples of 20-50 µL at a set sampling interval over 
a period of 2-48 hours.  The sampler should rapidly quench the removed reaction aliquot 
(within 2 seconds) and be capable of sampling from a reactor containing 30-50% of solid 
particles, with viscosities ranging from 0.2-6 Pas.  The sampler should be made from 
materials that are resistant to a range of chemicals, including organic solvents and 
corrosives.  Additionally, the sampler should be easily interfaced with the reactor, and 
transfer of sample to an analytical instrument after quenching and any additional sample 
processing should be automated.  When developing sampler designs, we used these 





Table 1-1.  Performance parameters for at-line sampling of a medium-scale research 
reaction. 
Performance Parameter Desired Range 
Reactor Vessel Size 50 - 500 mL 
Percent Solids 
(Heterogeneous Reaction) 30% - 50% 
Particle Size 
(Heterogeneous Reaction) 10 - 500 µm 
Sampling time 2 - 48 hours 
Sampling interval 5 minutes - 1 hour 
Sample size 20-50 µL 
Quench time 2 seconds 
Quench volume Up to 10x sample volume 
Delivery to analytical instrumentation Automated 
Compatibilities Organic solvents, corrosive materials 
Viscosity 0.2 to 6 Pas 
Temperature 20-130 °C;  -80 to over 130 °C desired 
Sample carryover Less than 1% 
Compatibility with reactor vessel 
Must not interfere with operation of 
reactor; must not require additional safety 
precautions 
 
Analytical Techniques for PAT 
 Real-time monitoring of drug product manufacturing has been dominated by 
vibrational spectroscopy because it is fast and can provide chemical information;5 
however, spectrometric methods are not ideal for all samples, particularly complex 
samples for which spectrometric analysis would be complicated by contaminants whose 
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spectra are similar to those of the desired analytes.6  Chromatographic techniques are 
powerful tools to gain information about chemical and biological processes in complex 
mixtures.  Gas chromatography (GC), the workhorse instrument of traditional online 
analysis, is less suited to water-based analysis3 for the increasing number of biologics. 
High-pressure liquid chromatography (HPLC) (without coupled mass spectrometry) 
represented 53% of analysis of impurities in drugs from 1995-2001.  The majority of 
these used reverse phase HPLC (RP-HPLC) with ultraviolet (UV) absorbance detection.7 
Developments in fast liquid chromatography,8, 9 such as ultra high pressure liquid 
chromatography (UPLC),10 high-temperature liquid chromatography (HTLC),11 and the 
use of monolithic columns,12 led to assay turn-around of 3-5 minutes which makes HPLC 
increasingly capable of real-time process monitoring in the pharmaceutical industry. 
 
Automated Reaction Monitoring 
 Sampling systems may be batch systems that remove a single sample of pre-set 
volume or continuous systems.  Batch systems have been used for process monitoring of 
monoclonal antibody production in fermentation vats.  A system that injects fermentation 
broth sample (including a small number of cells) directly onto an HPLC column, without 
filtration or dilution, was reported (Figure 1-1).13  This system is illustrative of sampling 
systems that do not perform sample prep, but simply remove sample from a reactor and 
inject it directly to an analytical instrument, in this case, HPLC.  A similar system was 
developed for monitoring production of ethanol from glucose in a fermentation reactor.14 
The system removes aliquots from the fermentation broth followed by automated 
filtration, dilution and injection onto the HPLC.  This system uses a Zymarc BenchMate 
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II,15 a robotic arm system that performs mixing by tilting vials.  The fermentation 
monitoring system (Figure 1-2) illustrates a primary goal of PAT: information about 
glucose and ethanol content in the broth is used to adjust system inputs such as gas flow 
and pH to insure the most productive turnover of glucose to ethanol possible.  
 
Figure 1-1.  BioCAD HPLC system for fermentation broth monitoring.  Used with 
permission from source.13  This system removes aliquots of fermentation broth and 
directly injects them onto an HPLC column without sample dilution or filtration. 
 
 Microdialysis (MD) coupled to HPLC is an example of a continuous monitoring 
system.  MD allows for selective sample collection, leaving particulate matter and 
proteins in the reaction vessel while transporting smaller analytes of interest for analysis 
via HPLC.  MD coupled to HPLC has been used in many applications including 
monitoring in vivo,16-18 sampling from whole blood,19 and determination of metals in 
aqueous samples.20  However, MD is not suitable for all applications of PAT because the 
membranes are not compatible with organic solvents, and solids or larger analytes of 
interest are excluded from the sample. 
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Chromatography Column. Affinity separations were carried 
out with a 2.1 X 30 mm POROS AIM, protein A affinity column 
from PerSeptive Biosystems. 
Sampling Apparatus. A 30-cm length of 0.030 in. inner 
diameter PEEK tubing was inserted through the outlet of the 
cap. It extended from the back of the T-flask through the cap 
to the inlet of the sampling valve on the HPLC system. A 20-cm 
length of surgical tubing was also inserted in the cap to allow 
pressure equilibration and gas exchange. The system was kept 
sterile by a 0.2-pm filter at the end of the surgical tubing. The 
entire cap assembly (viz. the cap, the inlet tubing, and the outlet 
tubing) was autoclaved before attachment to the T-flask. 
Samples were drawn in triplicate from the flask at 2-h intervals. 
Although the sample loop volume was only 100 pL, 500 pL was 
drawn for each sample in order to flush the loop as well as the 
inlet tubing that extended into the T-flask. The loading buffer 
was 20 mM tris + 150 mM NaCl pH 7.0, and the desorption 
buffer was 12 mM HCl + 150 mM NaC1. The flow rate was 3.0 
mL/min, and detection was at 220 nm. A step gradient was used 
for antibody elution. The experiment was repeated three times 
and similar results were obtained. 
RESULTS AND DISCUSSION 
Sample Automatic 
Fraction Collection Bioreactor 
or Waste 
Flgure 1. BloCAD HPLC system. A 175-cm2 T-flask was connected 
dlrectly to the sample valve of the system. A 0.2-pm fllter was used 
for gas exchange and to filter out bacteria; 500 pL of media was 
flushed through the 100-pL sample loop for each sample durlng the 
time course. 
The function of this analytical system was to automatically 
monitor the production of immunoglobulin G (IgG) in a 
hybridoma culture. IgG is secreted from hybridoma cells 
where it accumulates in the growth medium. For this reason, 
cell disruption is not required for analysis. While the system 
was being designed, it was determined that the following 
features were critical: the capability to (1) aseptically sample 
cultures, (2) deal with cells in the analysis, (3) detect antibodies 
between the concentration limits of 1 and 100 gg/mL, (4) 
discriminate IgG from pH indicators and other proteins in 
the sample, (5 )  make analytical measurements within 1 min, 
(6) operate all aspects of the assay automatically, and (7) 
archive processed data. The design rationale for each of these 
features and the results of testing will be described below. 
Aseptic Sampling. Fermentation campaigns in modern 
fermentors can range from a few hours in the case of bacteria 
to 6 months with immobilized mammalian cells. During the 
course of a long campaign, it is necessary to provide the cells 
with oxygen and growth medium in addition to withdrawing 
fermentation product(s). Contamination of the culture with 
other rapidly growing organisms during invasive procedures 
is a constant problem, particularly in the case of slow-growing 
mammalian cells. A single bacterium in a 100-L fermentor 
can totally contaminate the fermentor in less than 2 days. 
Manual withdrawal of analytical samples carries the same 
risk of contamination. Attempts to construct an automated 
mechanical sampling system using pipeta or syringes were 
unsuccessful (data not shown). The contamination problems 
experienced in preliminary studies were apparently due to 
an inability to maintain the sterility of pipets or syringes for 
long periods of time during repetitive sampling. 
Fluid withdrawal through membranes has also been used 
to sample fermentors. Hollow fibers and tangential flow 
membranes have both been used successfully in large-volume 
sampling.* Although aspiration of samples through a 0.2-pm 
sterile membrane interface attached to the fermentor was 
successful, a membrane interface was not selected for the 
automated analytical system. Occasional plugging of the 
membrane interface, cavitation in transfer lines, and vari- 
ability in the volume of aspirated samples reduced the 
reliability of the membrane interface. 
The most reliable sampling device was the simplest. The 
BioCAD instrument is equipped with a computer-controlled 
sampling valve and variable-volume syringe for sampling up 
(8) Handa-Corrigan, A.; Nikolay, S.; Jeffery, D.; Heffernan, B.; Young, 
A. Enzyme Microb. Technol. 1992, 14, 5 8 4 3 .  
to four reaction vessels (Figure 1). Sampling rate may be 
varied from once per minute to several hours while sampling 
volumes of 5-5000 pL may be selected. Although only one 
fermentor was monitored in these studies, this instrument 
could monitor four reactors simultaneously if they were 
immediately adjacent. 
The fermentor was connected directly to one of the bulk 
sample inlets with a 30-cm length of sterile 0.762 mm inter al 
diameter tubing of - 137-pL internal volume. Samples (500 
pL) were withdra n in these studies to displace all of the 
liquid in the interface line and instrument. Stainless steel 
and Teflo  tubing appeared to be f qual efficacy. No 
attempt was made to sterilize any of the sample-contacting 
components of the BioCAD. Because sampling occurred with 
a frequency of every 2 h or less and fluid flow toward the 
valve swept foreign organisms from the interface tubing, even 
motile organisms could not traverse the 30-cm length of sterile 
tubing between sampling events. Interface tubing was 
replaced after several weeks to preclude the possibility of 
bacteria attaching to the walls and eventually growing back 
into the fermentor. This could be a problem in 6-month 
fermentation campaigns where it is undesirable to break sterile 
connections to the fermentor by replacing the interface tube. 
An air filter allowed gases to displace the liquid removed 
during sampling while sterility was maintained. 
Sampling events were programmed through the BioCAD 
computer. The time of fluid withdrawal from the fermentor 
and sampling volume were programmed as individual events 
in the sampling and gradient elution protocol for the 
chromatographic analysis. During most of the studies con- 
ducted, a linear set of commands was used to execute the 
analysis. This means that the instrument is only executing 
one operation at a time. When the rate of analysis is high, 
it is necessary to carry out operations in parallel; i.e., both 
sampling and column elution may be occurring simulta- 
neously. Because separate commands are used to ‘sample” 
and ‘inject” in the instrument, it is possible to sample the 
fermentor while the chromatography column is being eluted 
and inject the sample on the next chromatographic run. 
Sample was generally withdrawn 30 s before it was used for 
analysis. The first sample was discarded, and for subsequent 
injections, it is assumed that the biosynthetic activity of cells 
in the sample ioop would be nearly identical to those in the 
fermentor during this short time period and would still be 
representative of the bulk solution at  the time of analysis. 
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Figure  1-2.  Automated monitoring system with feedback control.  Used with 
permission from source.14  This system uses computer control to monitor ethanol 
and glucose content in the reactor and adjust the system inputs to improve ethanol 
production. 
 Flow injection analysis and related techniques.  Flow injection analysis (FIA) 
and its related techniques are powerful tools for automated sample processing that may 
be coupled to a collection of analytical methods for analysis of the processed sample.  
The evolution of FIA techniques has been recently reviewed,21 and use in the 
pharmaceutical industry, as well as common detectors and detection limits achieved has 
also been reviewed.22 FIA was first developed by Ruzicka23 in 1975 and has been used 
extensively since that time.  A typical FIA setup (Figure 1-3) consists of a peristaltic 
pump constantly pushing a carrier fluid through a two-position valve to a detector at a 
constant flow rate.  The sample is pulled through the two-position valve, filling a sample 
loop of fixed volume.  When the valve is triggered, the sample is injected into the flow 
stream, reacting with the carrier fluid as it moves through a holding coil.  The length of 
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the holding coil and the carrier fluid flow rate control the amount of the time that the 
sample reacts before flowing past the detector.23  
 
Figure 1-3.  Flow injection analysis (FIA).  Adapted from source24 with permission. 
 
 Sequential injection analysis (SIA), first developed in 1990, uses bi-directional, 
programmable flow rates to improve mixing and decrease reagent consumption.25  In 
contrast to FIA, where the carrier fluid is constantly flowing, SIA aspirates sample and 
reagents sequentially into a mixing coil. Reagents are flowed through the mixing coil, 
reversing direction and changing flow rates to enhance mixing.  Once the reaction is 
complete, the fluid flows past a detector for analysis (Figure 1-4).  SIA has been used for 
monitoring of analytes of interest in bioprocesses, such as L-cysteine26 and glycerol.27
 SIA has been used for online monitoring without chromatography to determine 
hydrogen peroxide content in lens cleaning solution with UV detection using an 
enzymatic reaction.28  One paper uses a combination of techniques to monitor a 
bioprocess.  Tubing with a filter on the tip is placed in the broth, continuously removing 
sample from the reactor.  Fluid is removed from the analysis stream to be analyzed using 




Figure 1-4.  Sequential injection analysis (SIA). The SIA system consists of a 
selection valve (SV), peristaltic pump (P), holding coil (HC), knotted mixing coil 
(MC), spectrophotometric detection system (D), sample or standard (S), reagent (R), 
buffer/carrier stream (C), waste (W).  Adapted from source.27  
 
 An improvement to the SIA design is the development of micro SIA lab-on-valve 
(µSI-LOV).30  The system miniaturizes SIA so that the flow cell and analysis are 
performed on the valve (Figure 1-5).  At the same time, the channels are large enough 
(500 µm) that small beads and other suspended matter (such as cells) can pass through the 
channels uninhibited.  Fiber optic technology is used to perform absorbance and 
fluorescence measurements within a flow cell cut into the valve itself.30  The µSI-LOV 
system has been used to monitor cell culture, using 60 µL of filtered sample for each 
assay. Assay controls were incorporated automatically using the µSI-LOV system.  The 
system had some problems with clogging of the sample tubing,31 a common problem for 
these types of systems. The µSI-LOV system was used for online monitoring of ammonia 
in E. Coli culture broth.32  Broth was removed for analysis at a flow rate of 0.5 mL/min, 
with analysis of a portion of the sample every 6 minutes.32  The uSI-LOV system has 
been demonstrated coupled to capillary electrophoresis (CE),33, 34 adding the advantage of 






 Chromatographic systems.  The addition of monolithic columns to SIA created 
sequential injection chromatography (SIC), which added the advantages of 
chromatography to the system for simultaneous detection of multiple analytes (Figure 1-
6).  The first system to incorporate a monolithic column35 separated four components 
(methylparaben, propylparaben, sodium diclofenac and butylparaben), all detected using 
UV absorbance.  Subsequent systems have been used to detect a variety of analytes, 
including food and cosmetic additives,36 and pesticides.37  This family of techniques, 
particularly µSI-LOV and SIC, are very promising for pharmaceutical applications.  The 
systems can be easily automated, are amenable to sample sizes in the µL range, and have 
been demonstrated with solids (beads and cells) in the samples when a suitably wide-bore 
is used in the valve.  The majority of research and development for these systems has 




Figure 1-6.  Sequential injection chromatography (SIC). Scheme of SIC set-up: 
CCD UV–vis detector (CCD); monolithic column (MC); mobile phase (MP);  6-port 
multi-position valve (MV); computer (PC); syringe pump (SP); solenoid valve (SV); 
Sample lines 1, 2, 3 (S1, S2, S3); UV lamp (UV); waste (W), Z-flow cell (Z-FC).  
Used with permission from source.37 
 
 The ExpressRT-100 reaction monitoring system (Eksigent, Dublin, CA, US) is 
based on Eksigent’s previous development of capillary liquid chromatography systems 
for rapid analysis.  The reaction monitoring system utilizes a sampling module (10 cm 
wide x 15 cm deep x 20 cm high) that is placed next to a reactor located in a hood.  The 
sampling module is connected to a capillary LC system which sits on a separate cart, 
allowing easy access to multiple reactors.  Sampling and analysis can take place as 
quickly as every three minutes.  It can pull up sample volumes as small as 20 µL and 
dilute the sample to a pre-programmed dilution factor from 1-1000 in a dilution chamber.  
All wetted parts are chemically-resistant (fluoropolymers, fused silica, stainless steel). 
Clogging was observed when sampling from heterogenous samples.  A filter was added 
at the tip of the sampling capillary to alleviate clogging in some solutions.6   A 
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subsequent paper demonstrates use of the sampling system with flow chemistry 
(continuous flow reactor).38 
 
Figure 1-7.  ExpressRT-100 reaction monitoring system.  Used with permission from 
source.6 
 Waters (Milford, MA, US) has developed the PATROL UPLC Process Analyzer 
for rapid analysis using UPLC.  They have demonstrated the ability to monitor the  
hydrolysis of acetylsalicylic acid by directly injecting the sample.39  While they have 
demonstrated that UPLC is sufficiently fast to monitor reactions, they have not developed 
any system for sample quenching or processing before injection. 
 Groton Biosystems (Boxborough, MA, US) has developed a stand-alone process 
analyzer (GPA1000) that is capable of removing samples from a reactor, and performing 
sample preparation steps in approximately 15 minutes.  Prepared samples are analyzed 
with a capillary electrophoresis (CE) system built in to the unit.  Total sample preparation 
and analysis time is estimated at 45 minutes.  While the system is automated and has 
been created specifically for process monitoring, it is only suitable for reactors larger than 
one liter, as each sample ranges from 0.5-5 mL in required volume. 
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 Groton Biosystems has also created a sophisticated system for monitoring 
fermentation reactors, the ARS-M.  This system pulls up aliquots of sample using either 
disposable needles or tubing (with our without filters, depending on the assay desired) 
and is able to perform dilution, filtration, cell lyzing and reagent addition automatically.  
The ARS-M system can be coupled to HPLC, cell-counting instruments, or to a sample 
collector if samples are to be analyzed at a later time.  The system uses PEEK, stainless 
steel and fluoropolymers for all wetted surfaces to improve chemical compatibility.  
While the system is capable of quite a few operations, it is still primarily suitable for 
large-scale reactions as sample volumes are in the milliliter range based on the dead 
volume of the system.40 
 
Dissertation Overview 
 While some systems have been developed for pharmaceutical PAT, they may be 
improved.  Many of the systems require volumes of sample (tens of microliters up to 
milliliters per data point) that are not compatible with monitoring small-scale reactions.  
This inhibits the use of these systems with early development of an API synthesis where 
the reactor volume may only be a few milliliters total volume.  As a result, initial HPLC 
analysis of a new reaction system would have to be performed manually.  Automated 
analysis with samplers capable of removing very small volumes of fluid (sub-microliter) 
would provide considerable time and cost savings by not needing a researcher to 
manually remove samples over a period of hours.  Additionally, being able to study the 
API synthesis prior to scaling up provides additional information so researchers may 
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determine if a particular API candidate should be considered for further investment or 
removed from the pipeline. 
 The other primary challenge in process monitoring systems is representative 
sampling from heterogeneous samples that contain solids.  This is a particularly difficult 
challenge when removing small sample sizes.  Several sampling systems have installed 
filters on intake tubing as a way to bypass this problem, while others only attempt to 
sample from homogeneous samples.  Many API synthesis reactions contain solid 
particles.  In biological reactions, cells and cell debris are present in the reactor.  In 
organic reactions, reagents may be present at a concentration that they precipitate out of 
the solution, or solid catalysts may be used to speed up the process.  We have attempted 
to directly sample from solutions with particles and investigated how solids may affect 
our sampling system. 
 The overall objective of this work was to develop sampling systems that could 
remove a small volume of sample (microliter range), quench the reaction, and perform at-
line HPLC analysis.  In chapter 2 we present a sampler design for continuous sampling 
using less than a microliter of sample for each minute of sampling.  This “push-pull” was 
built from fused silica capillary and a PEEK tee and fittings, ensuring chemical 
compatibility with a wide range of reagents (although long-term use at high pH is not 
recommended).  The design takes advantage of rapid passive mixing (seconds) 
characteristic of microfluidic systems.  The sampler was characterized with samples of a 
varying viscosity and has been tested with heterogeneous samples containing polystyrene 
beads.  The push-pull sampler was demonstrated monitoring both an enzymatic reaction 
without a chromatographic component, and monitoring the hydrolysis of acetylsalicylic 
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acid to salicylic acid while coupled to an analytical-scale HPLC instrument.  Data and 
results from this chapter have been accepted for publication in the Journal of 
Chromatography A.   
 In chapter 3 we present a second sampler, capable of batch sampling with even 
smaller sample volumes (sub-microliter per data point).  This “droplet” sampler takes 
advantage of the properties of segmented flow microfluidics to mix the sample and 
quenchant.  As this sampler is connected to a movable stage, multiple reactions may be 
analyzed using the same system.  This sample is coupled to the HPLC for analysis of the 
small sample volumes.   
 The final sampler, presented in chapter 4, directly tackles the challenge of 
heterogeneous samples.  This “soup pot” sampler is a custom-built borosilicate glass 
chamber for mixing sample with quenchant and diluent.  A syringe is used to obtain 
sample and is subsequently used for mixing the sample with quenchant/diluent in the 
chamber.  A Teflon stopcock has been modified to allow access to the reactor vessel 
while also providing a leak-free seal during mixing.  The sampler is coupled to an 
analytical-scale HPLC and has been demonstrated for reaction monitoring of dibutyl 
phthalate hydrolysis.  These samplers represent prototypes for further development of 





DEVELOPMENT AND CHARACTERIZATION OF “PUSH-PULL” SAMPLING 





 In this work, we describe a microscale sampling system suitable for near real-time 
monitoring of very small-scale reactions (several milliliters), inspired by push-pull 
perfusion systems used for neuroscience.41, 42  As discussed previously, sampling from 
very small reactions requires the removal of very small volumes of sample so as not to 
affect the reaction system while in the process of monitoring the system.  The 
development of an automated system for very small volume sampling provides 
considerable cost advantages for a pharmaceutical company because they are better able 
to understand the reaction early in the scale-up process, determining whether they should 
continue to develop the active pharmaceutical ingredient (API), and they are not required 
to pay for a researcher to perform manual sampling over a period of hours. 
 Microfluidics is a growing area of research and microfluidic systems have been 
extensively reviewed over the last year,43-47 including advances in microfluidic 
separations,48-51 detection methods for microfluidic systems,52-55 and numerous 
applications.56-76  Microfluidic systems have characteristic length on the order of 
micrometers to millimeters and are advantageous due to their very small reagent 
requirements, large surface-to-volume ratio that allows for rapid reactions, and rapid 
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dispersion of heat which aids in developing very fast separations techniques such as 
capillary electrophoresis (CE).  Due to their small characteristic lengths, most 
microfludic systems have laminar flow properties unless operated at high flow rates.  In a 
laminar system, mixing is controlled by diffusion across a channel or tube.  This leads to 
unique devices that could not be created at a larger scale, such as the H-filter,77 which 
extracts small molecules from one flow stream into a secondary flow stream, leaving 
larger proteins and particles behind.  The push-pull device developed here used laminar 
flow for very predictable adjustment of flow properties, and used the rapid mixing at the 
microfluidic scale to perform rapid quenching of a sample as it is removed from a reactor. 
  The device performs automated sampling with rapid (seconds) passive mixing 
with a quenchant/diluent and downstream reaction monitoring.  The small dimensions of 
the sampler body take advantage of the properties of microfluidic systems, including 
rapid passive mixing and minimal reagent consumption.  Rapid mixing ensures that as 
sample is removed from the reactor, the reaction may be quenched so that reaction 
conditions are maintained until the sample may be analyzed downstream.  The low 
(µL/min) reagent consumption reduces cost and waste for analysis, while also allowing 
the sampler to be used with small-scale (mL) reactions such as may be seen in a research 
and development environment.  Under normal operating conditions, withdrawing sample 
from a reactor at 0.5 µL/min, only 0.72 mL of sample would be consumed after a full 24 
hours of continuous sampling. 
 Unlike a microfluidic chip system, commonly made from glass or polymers such 
as polydimethylsiloxane (PDMS), the sampler body is made entirely from commercially 
available parts that are easily exchanged and do not need specialized facilities to produce.  
  19 
The sampler body is constructed from fused silica capillary and polyether ether ketone 
(PEEK), materials that make it amenable to a wide variety of analytes.  Both materials 
have low chemical reactivity, even with organic solvents and corrosives, and may be used 
over a range of temperatures.  The main sampler body is connected to two syringe pumps 
to drive flow and mixing, minimizing the number of parts that have the potential to fail 
during sampling.  The sampler was connected to three monitoring systems, and was 
computer-controlled with software written in LabVIEW, making operation simple for the 
end-user. 
 We have demonstrated the ability of the sampling system to monitor reactions 
with a temporal resolution of less than one minute, and a delay time of several minutes 
(limited by length of capillary from sample to detector) with automated data collection 
and system control.  Finite element modeling of the sampler shows that it can rapidly 
dilute or quench reactions and quenching has been confirmed experimentally.  We have 
investigated the effect of particulate matter and viscosity on the system.  A modification 
to the system, stop-flow sampling, which would let sample consumption be minimized if 
samples were only needed infrequently, was considered.  Finally, we monitored two 
separate reactions, with the sampler coupled to two different detection systems to 
demonstrate its utility for monitoring real reactions. 
 
Experimental Section 
 Materials.  Blue food color (water, propylene glycol, FD&C Blue 1, 0.1% 
propylparaben) was obtained from McCormick (Sparks, MD, US).  Amplex Red (10-
acetyl-3,7-dihydroxyphenoxazine) and Amplex Red Stop Reagent (proprietary) were 
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purchased from Invitrogen (Carlsbad, CA, US).  Acetylsalicylic acid and salicylic acid 
were obtained from Acros Organics (Morristown, NJ, US).  All water used was deionized 
to 18 MΩ resistivity with an E-pure 1090 series system from Barnstead Thermolyne 
Cooperation (Dubuque, IA, US).  Unless otherwise noted, all other chemicals were 
purchased from Fisher Scientific (Chicago, IL, US). 
 Sampler assembly.  The sampler was constructed using three fused silica 
capillaries (Polymicro Technologies, Phoenix, AZ, US) and a mixing tee (Valco 
Instruments, Houston, TX, US) as shown in Figure 2-1.  One end of the push capillary 
(40 µm ID, 100 µm OD) was connected to a Fusion 400 (push) syringe pump (Chemyx, 
Inc., Stafford, TX, US) and the other end was inserted completely through the mixing tee 
and sheathed within the pull capillary (250 µm ID, 360 µm OD).  The transfer capillary 
(150 µm ID, 360 µm OD) connected the tee sidearm to a PHD2000 (pull) syringe pump 
(Harvard Instruments, Holliston, MA, US).  Fluid was continuously pulled up from the 
sample, mixed with quenchant/diluent from the push capillary in the mixing zone, and the 
mixed solution was pulled into the transfer capillary. 
 Mixed sample flow was monitored in one of three configurations: direct 
monitoring, FIA monitoring, and HPLC monitoring.  In all three configurations, 
ultraviolet (UV) absorbance within a capillary was measured with a Spectra 100 variable 
wavelength detector (Spectra Physics, Mountain View, CA, US).  The detector output 
was recorded with USB-6008 DAQ card combined with LabVIEW (National 
Instruments, Austin, TX, US) software written specifically for this application. 
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Figure 2-1.  Illustration of the push-pull sampler (not to scale).  Sample is 
continuously pulled into the sampler body with the pull syringe where it is rapidly 
mixed with fluid from the push pump upstream of the push capillary tip in the 
mixing zone.  The mixed solution is pulled through the tee and out the transfer 
capillary, where it may be analyzed.  See Appendix C for more details about push-
pull sampler assembly. 
 
 For direct detection monitoring (Figure 2-2 A), a small area of polyimide coating 
was removed from the surface of the transfer capillary to allow for transmittance of UV-
light through the capillary, and mixed sample was detected using the variable wavelength 
detector.  For FIA monitoring, an 8-port 2-position switching valve (Valco Instruments) 
was added between the sampler body and the pull pump.  The valve was fitted with two 
0.5 µL fused silica capillary injection loops.  A third (carrier) syringe pump was attached 













through the valve to fill the injection loop and then injected every minute from the loop 
into the carrier flow stream.  While one loop was being filled, the other loop was injected.  
A window was burned in the carrier capillary and injected sample was detected with the 
variable wavelength detector described previously.  
 For experiments using HPLC monitoring (Figure 2-2 C), 2 µL stainless steel 
sample loops were installed on the 8-port switching valve used for FIA.  Sample was 
injected every 5 minutes onto a 150 long x 4.6 mm ID column packed with 5 µm Grace 
Prosphere HP C4 particles (Grace Davison Discovery Science, Deerfield, IL, US) 
installed on an Agilent 1100 HPLC (Agilent Technologies, Inc., Santa Clara, CA, US).  
The sample was separated isocratically with 35% methanol, 65% 10 mM monopotassium 
phosphate (pH 2.3) as the mobile phase.  A variable wavelength detector, described 




Figure 2-2.  Illustration of the push-pull sampling system.  Overview (not to scale) of 














A. Direct Monitoring 
B. FIA Monitoring 
C. HPLC Monitoring 
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 COMSOL Multiphysics Modeling.  A finite element modeling program, 
COMSOL Multiphysics 3.5a (COMSOL, Inc., Burlington, MA, US), was used to model 
fluid flow and mixing within the nested capillary system.  A 3 mm segment of the 
sampling tip was modeled in three dimensions, with the push capillary recessed 1 mm 
vertically from the tip of the pull capillary (Figure 2-3) and 15 µm horizontally from one 
side of the pull capillary to match the arrangement used for experiments.  Area A is 
defined as an inlet with laminar volumetric flow and a concentration of 1 mM.  Area B is 
defined as an open boundary for fluid flow with a concentration of 0 mM.  Area C is 
defined as an outlet with laminar volumetric flow and an open boundary for convection 
and diffusion.  Modules for incompressible, isothermal fluid flow and convection and 
diffusion were used.  Constants for water at 20 °C (density of 998.207 kg/m3 and 
viscosity of 1.002 x 10-3 Pas) were used for the model.  The diffusion coefficient was set 




Figure 2-3.  COMSOL model of the push-pull sampler.  This model was used for 
determining the effect of sample capillary diameter on mixing time, the effect of 
flow rate on mixing time and the correct offset distance between the tip of the pull 
capillary and the tip of the recessed push capillary to ensure quenchant does not 
leak into the bulk sample.  A. Three-dimensional view of a 3 mm segment of the 
sampling tip with nested push capillary offset by 1 mm. Area 1 is defined as an inlet 
with a volumetric flow rate of 0.5 µL/min and a quenchant concentration of 1.0 mM.  
Area 2 is defined as an open boundary with free flow of fluid and a defined 
quenchant concentration of 0.0 mM.  Area 3 is defined as and outlet with a 
volumetric flow rate of 1.0 µL/min and an open boundary for mass transport.  B. 
Side view of the modeled sampling tip showing sample (0.0 mM) mixing with 
quenchant/diluent (1.0 mM) at a pull flow rate of 1.0 µL/min and a push flow rate of 
0.5 µL/min. 
 
  On-line Dilution.  Dilute blue food color (in water) was sampled at a 
constant flow rate (1.0 or 2.0 µL/min).  The flow rate of water through the push capillary 
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was varied to dilute the mixed sample to different degrees.  FIA was used to monitor the 
degree of sample dilution. 
 Delay and Response Time.  Delay and response times were determined using 
direct monitoring.  Every 10 minutes, 100 µL of blue food color was added to a stirred 
vial containing a constant volume of water.  The pull flow rate was set to 1.0, 2.0 or 3.0 
µL/min.  Water was pumped through the push capillary at 50% of the pull flow rate.  
Absorbance was recorded at 280 nm using direct monitoring.  The experiment was 
repeated, directly dipping the transfer capillary (with the sampler removed) into the 
sample vial, isolating the contribution to delay and response times due to the length of 
transfer capillary only.  
 Stop-Flow Sampling.  The system was modified by placing a six-port switching 
valve between the push syringe pump and the push capillary to enable rapid switching 
between two push flow rates.  Syringes were filled with water and connected to the six-
port valve adjacent to the push capillary.  Two inlet capillaries, of equal dimension to the 
push capillary, were attached to the six-port valve adjacent to the inlet capillaries, 
equalizing the pressure drop when the valve was actuated.  One syringe was set to 0.9 
µL/min (sampling “off”) and the other was set to 0.1 µL/min (sampling “on”), while the 
pull flow rate was set to 1.0 µL/min.  Blue food color, diluted in water, was used as the 
sample.  The resulting mixed sample/water solutions were monitored using FIA. 
 Particles.  Solutions of blue food color diluted in ethanol were prepared with 
10.0, 100 or 500 µm polystyrene beads.  Each solution was sampled at 1, 2 and 4 µL/min 
pull flow rate with isopropanol flowing at a constant 0.5 µL/min through the push 
capillary.  To determine the effect of bead concentration on reproducible sampling, serial 
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dilutions (1:10) of 10.0 µm particles were made in blue food color (diluted in ethanol).  
Each solution was sampled at 1, 2 and 4 µL/min pull flow rate with a constant 0.5 
µL/min isopropanol push flow rate.  All mixed solutions were monitored with FIA. 
 Viscosity.  Samples of varying viscosity were prepared by mixing a constant 
volume of blue food color (diluted in ethanol) with isopropanol and glycerol.  
Isopropanol was pumped through the push capillary as a model quenchant/diluent.  To 
determine the maximum pull flow rate for a given viscosity, the push flow rate was held 
constant at (0.1 µL/min).  The pull flow rate was initialized at 1.0 µL/min and increased 
by 1.0 µL/min every 20 minutes until cavitation was observed in the pull syringe.  To 
determine if sampling is reproducible across a range of viscosies, within the allowed flow 
rates for each viscosity, peak height reproducibility was monitored using FIA, with the 
push flow rate set to 50% of the pull flow rate. 
 Verification of quenching using an enzymatic reaction.  Amplex Red was 
prepared in dimethylsulfoxide according to manufacturer directions.  Amplex Red Stop 
Reagent was prepared with ethanol and water according to manufacturer directions.  
Samples of 200 µM Amplex Red were prepared in 50 mM phosphate buffer (pH 7.4) 
with 1, 2 or 4 milliunits per milliliter (mU/mL) horseradish peroxidase (HRP).  An equal 
volume of 8.8 mM hydrogen peroxide in the same buffer was added to the sample to start 
the reaction (diluting all reagents by ½).  Amplex Red Stop Reagent was used as a 
quenchant to stop the reaction.  The pull flow rate was 1.0 µL/min with Amplex Stop 
Reagent push flow rate of 0.167 µL/min, mixing sample with stop reagent at 5:1 ratio 
according to manufacturer instructions.  The quenched sample was monitored every 
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minute with FIA at 570 nm, using 50 mM phosphate buffer at 5.0 µL/min as the carrier 
fluid. 
 To verify quenching and show that the reaction may be monitored online as well 
as offline the experiment was repeated with 1 mU/mL HRP.  While sampling with the 
push-pull sampler, 200 µL aliquots were removed manually every one minute and 
quenched offline by adding to 40 µL Amplex Red Stop Reagent in a microtiter plate.  
Absorbance for the offline samples was measured at 570 nm on a plate reader and 
compared to the online absorbance. 
 Reaction monitoring with HPLC.  Base-catalyzed hydrolysis of acetylsalicylic 
acid (aspirin) was monitored with HPLC monitoring.  A 0.2 M solution of acetylsalicylic 
acid was prepared in methanol.  A stirred vial containing 14.5 mL of 25 mM bicarbonate 
buffer (pH 11.2) was sampled at a pull flow rate of 1.0 µL/min.  A constant push flow 
rate of 0.5 µL/min was applied with 10 mM monopotassium phosphate as the quenchant, 
which changed the pH of the mixed solution to approximately 7, quenching the 
hydrolysis.  After 5 minutes of sampling, 0.5 mL of the acetylsalicylic acid solution in 
methanol was added to the sampling vial, starting the hydrolysis reaction.  The reaction 
was monitored for 110 minutes using HPLC. 
 
Results and Discussion 
 Sampler Design.  The heart of the push-pull sampler is a pair of concentric fused-
silica capillaries.  Solution is pulled through the outer (pull) capillary directly to an HPLC 
valve (or on-line detector) using a syringe pump (Figure 2-1).  At the same time, the 
diluent/quenchant solution is pushed through the center (push) capillary with a syringe 
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pump, mixing with the sample solution in the mixing zone as it moves toward the mixing 
tee.  Solution added through the push capillary can be used to dilute the sample and may 
include quenchant to stop the reaction.  By varying the flow rate through the push 
capillary, it is possible to change the degree of sample dilution.  To ensure that the push 
solution does not contaminate the reaction vessel, the sampler capillaries were arranged 
so that the push capillary was recessed within the pull capillary. 
 While this system is similar to push-pull capillary systems used for in vivo 
monitoring,41, 42 it differs in two ways.  First, in vivo push-pull samplers use the same 
flow rate for the push and pull solutions to avoid changing the volume of extracellular 
fluid.  By using different flow rates, we can adjust dilution or quenching of the sample.  
Secondly, for in vivo sampling, the inner and outer capillaries are flush at the end to 
provide a region of solution exchange with the extracellular space.  In our case, recessing 
the push capillary prevents contamination of the sampled solution.  In principle, adding 
solution at a tee downstream of sampling could fill the role of the push solution for 





Figure 2-4.  Effect of push flow rate on mixing with a constant pull flow rate.  A. 
COMSOL models showing effect on mixed concentration and spatial distribution of 
quenchant.  B. Distance from push capillary tip (mm) where concentration of 
quenchant/diluent decreases to <1% of the original concentration.  The pull flow 
rate was kept constant at 1.0 µL/min while the push flow rate was increased.  It was 
determined that up to a flow rate of 0.95 µL/min an offset of 1 mm was sufficient to 
prevent leakage. 
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Sampling tip modeling with COMSOL.  We modeled the push-pull sampler system 
using COMSOL with the basic construction shown in Figure 2-3.  As shown, the 
diluent/quenchant and sampled solution mix within the pull capillary and reach 
homogeneity downstream from the sampling tip as it flows toward the mixing tee.  
Furthermore, the diluent/quenchant solution does not reach the sampling tip and therefore 
does not contaminate the reaction solution (Figure 2-4 A).  Using this basic model, we 
examined how the pull capillary ID, flow rates, and distance between the outer tip of the 
push and sample capillary (offset) affect performance parameters such as time required 
for mixing of quenchant with sample.  We also evaluated what conditions would prevent 
leakage of diluent/quenchant into the reaction solution. 
Table 2-1.  Modeled effect of pull capillary ID on mixing time and travel time.  Pull 









 Sample capillary inner diameter.  The effect of sample capillary diameter was 
modeled (structure shown in Figure 2-3) to determine suitable dimensions for 
construction.  Mixing time was defined as the time required to reach ≤ 5% variation in 
concentration across a plane perpendicular to the pull capillary, upstream of the pull 
capillary tip.  Travel time was defined as the time required for sample to flow from the 
Pull Capillary I.D. Mixing Time Travel Time Total Time 
 
150 µm 3.5 s 2.6 s 6.1 s 
200 µm 3.5 s 2.8 s 6.3 s 
250 µm 4.3 s 3.8 s 8.1 s 
300 µm 8.6 s 5.0 s 13.6 s 
400 µm 17.2 s 8.3 s 25.4 s 
400 µm (centered) 9.4 s 12.4 s 21.8 s 
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outer tip of the pull capillary to the tip of the push capillary at the modeled flow rate.  The 
effect of the pull capillary ID on time required to reach complete mixing is summarized 
in Table 2-1.  Increasing the diameter dramatically increases the model-predicted mixing 
time because the solutions mix primarily by diffusion under the flow rates tested.  
Increasing the pull capillary ID also increases travel time due to a slower linear flow 
velocity.  Although short mixing times are desirable, we found that fabricating the 
sampler with a pull capillary ID <250 µm was difficult because the push capillary was 
very flexible and tended to rest against the pull capillary.  Therefore, the sampler design 
tested had a 250 µm ID pull capillary.  The nested capillary system was modeled with the 
push capillary off-center in the pull capillary, based on observations of the push capillary 
resting against the pull capillary in initial sampler prototypes.  Further decreases in 
mixing time can be achieved by centering the push capillary within the pull capillary (see 
Table 2-1); however, using the materials and methods described here, it was difficult to 
achieve centered capillaries.  
 Effect of modeled flow rate on mixing.  We next evaluated the effect of flow 
rates on mixing time.  The time required for complete mixing increases with decreased 
pull flow rate when the push flow rate is modeled at 50% of the pull flow rate (Table 2-
2).  Time required for mixing is increased by less than 1 s for a 10-fold decrease in pull 
flow rate.  Because mixing is primarily diffusion-controlled and thus dependent on the 
width of the channel, the slower mixing time at lower flow rates is due to a higher 
percentage of time spent in the wider pull channel before being swept into the more 
narrow space between the push and pull capillary where mixing occurs more rapidly.  
The difference in travel time from 3.8 to 37.4 s for the same 10-fold decrease in pull flow 
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rate is much more dramatic.  To minimize the effect of travel time, the offset between the 
pull capillary and the recessed push capillary may be decreased to <1 mm at lower flow 
rates. 
Table 2-2.  Modeled effect of flow rate on mixing time and travel time.  When 
relative push-to-pull flow rate is held constant, an increase in pull flow rate results 






Mixing Time Travel Time Total Time 
0.1 µL/min 0.05 µL/min 4.7 s 37.4 s 42.1 s 
0.5 µL/min 0.25 µL/min 4.5 s 7.5 s 12.0 s 
1.0 µL/min 0.5 µL/min 4.3 s 3.8 s 8.1 s 
2.0 µL/min 1.0 µL/min 4.3 s 1.9 s 6.2 s 
 
 Relative push flow rates and capillary offset.  Modeling was used to determine 
the appropriate offset between the pull capillary tip and the recessed push capillary 
(marked on Figure 2-3 B).  The offset needs to be small to minimize time between when 
the sample is removed from the reaction vessel and when it is mixed with 
diluent/quenchant.  If the offset distance is too short, however, the diluent/quenchant may 
be able to leak into the bulk solution, affecting the ongoing reaction that is being 
monitored.  It was determined that for a push flow rate of 95% of the pull flow rate, the 
distance to which the diluent/quenchant spread (local concentration 1% of the original 
quenchant concentration) was 0.51 mm (Figure 2-4).  Based on this result, a 1 mm offset 
should be sufficient to ensure that the diluent/quenchant does not leak into the bulk 
sample for a push flow rate up to 95% of the pull flow rate.   
 In practice, when blue food color, diluted in water, was flowing through the push 
capillary, leakage into the bulk solution was observed visually when the push rate was 
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only 90% of the pull rate.  This discrepancy may be due to small fluctuations in the flow 
rate due to pulsing from the syringe pumps.  We used a 1 mm offset distance in all 
subsequent investigations, but a shorter offset distance could be used to facilitate faster 
mixing if a lower push flow rate is used. 
  On-line Dilution.  The total volumetric flow rate through the pull capillary is the 
sum of the volumetric flow rates through the push capillary and the volumetric flow rate 
from the sample.  Therefore, adjusting the ratio of the push to pull volumetric flow rates 
controls the mixing ratio of the sample with either a quenchant or diluent.  For a constant 
pull flow rate, increasing the push flow rate should result in predictable dilution of the 
sample.  To confirm this performance, we varied the push flow rate with a constant pull 
flow rate while sampling dilute blue food color and monitoring the resulting using the 
direct monitoring system.  We found that diluting resulted in the expected decrease in UV 
absorption (Figure 2-5) for diluted sample as measured downstream.  These results also 
match modeling data (Figure 2-4B).  These results further supported that the push 
solution does not leak out of the sampler and demonstrated predictable operation of the 
sampler for on-line dilution.   
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Figure 2-5.  Peak areas versus push-to-pull flow rate.  As the relative push-to-pull 
flow rate increases, the sample is more diluted.  Peak area decreases linearly with 
increasing relative push-to-pull flow rates. 
 
 Delay and Response Time.  An inherent delay time exists between the time 
sample is collected and the time that signal is detected downstream of the sampler.  Delay 
time is defined as the difference between the time when a chemical that causes a change 
in absorbance (observed downstream) is added to the stirring sample vial and when 50% 
of the maximal value of the step change is observed at the detector.  Response time is 
defined as the time required to observe a change from 10% to 90% of the maximal value 
following a step change in analyte concentration.  Delay times ranged from 111.5 ± 3.4 s 
to 317.0 ± 8.8 s (Table 2-3), depending on the flow rate and agreed with expected delays 
based on tubing volume.  Response times varied from 26.6 ± 1.0 s to 52.4 ± 5.8 s over the 
same flow rate range.  Tests performed without the sampler and only the transfer tubing 
revealed that both parts of the system contributed significantly to the delay and response 
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time.  These results suggest the limits of feedback control and rate of reaction that can be 
monitored by this approach.  
Table 2-3.  Delay and response time.  Time (s) is ± standard deviation (n=3) for each 
value.  Step changes in blue food color concentration were recorded with the 
sampler connected to the detection capillary as well as with the sampler removed (to 










 Stop-flow sampling.  The sampler was designed for continuous sampling; 
however, with small samples or slow reactions, it may be advantageous to run the 
sampler in a non-continuous mode to minimize sample consumption.  One approach is to 
remove the sampler from the solution, but this may not always be feasible depending on 
the reactor.  Therefore, we examined using flow effects within the sampler to stop and 
start sampling.  As discussed above, the total pull flow rate is equal to the sum of the 
sampling flow rate and the push flow rate.  This allows the sampling flow rate to be 
decreased by increasing the push flow.  If the push rate equals the pull flow rate, there 
would be no sampling; however, the push solution would likely diffuse into the reaction 
solution.  Experimentally, we observed that the push flow rate could be increased to 90% 
of the pull flow rate without push solution leaking into the reaction vessel.  At this 
fraction, the sampling flow rate was only 10% of the total pull flow rate and nearly 
 Delay Time Response Time 
Pull Flow Rate Sampler No sampler Sampler No sampler 
1 (µL/min) 317.0 ± 8.8 s 203.9 ± 3.6 
s 
52.4 ± 5.8 s 19.6 ± 1.3 s 
2 (µL/min) 160.0 ± 1.2 s 103.3 ± 3.9 
s 
34.9 ± 2.2 s 11.9 ± 0.8 s 
3 (µL/min) 111.5 ± 3.4 s 69.1 ± 1.8 s 26.6 ± 1.0 s 10.4 ± 0.5 s 
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stopped, e.g. at 1.0 µL/min, only 100 nL/min of sample was withdrawn.  By modulating 
the push flow rate between 10% and 90% of the pull flow rate, sampling could be 
effectively switched from “on” to off”. 
 
Figure 2-6.  Stop-flow sampling.  A. Plot showing FIA peaks when the push flow 
rate is switched from 10% of the total pull flow rate (“sampling on”) to 90% 
(“sampling off”) and back to 10% every 15 minutes.  This feature may be used to 
control sample consumption when continuous sampling is not desired.  B. Zoomed 
view of FIA peaks. 
 To demonstrate the possibility of stopping and starting sampling in this way, we 














































capillary.  Sampling was performed at 1.0 µL/min and the mixed solution was monitored 
by FIA.  Switching the flow rates from 0.1 µL/min (“on”) to 0.9 µL/min (“off”) showed a 
change in the FIA peak heights in less than 5 minutes.  Switching sample flow to “on” 
had a faster response of less than 3 minutes (Figure 2-6).  Although the process of 
minimizing sample flow is not fast, it may be useful for conserving sample during slow 
reactions.  While monitoring an enzymatic reaction, the reaction could be monitored 
continuously during the rapid early substrate turnover, and stop-flow sampling could be 
used for monitoring the reaction as turnover slowed. 
 Particles.  While this sampler was designed for homogenous samples, 
pharmaceutical reactions may have solid particles present, either cells and cell debris for 
biological reactions, or solid catalysts and precipitated reagents for organic synthesis 
reactions.  We investigated the effect of particulates on sampling using polystyrene 
beads.  We first tested beads of several different sizes, suspended in solution, to 
determine any differences in sampling as compared to a solution with no beads present 
(Figure 2-7 A).  It was determined that 10.0 µm beads generally passed through the 
sampling system and the peak heights were the same as a solution with no particles.  At 
higher flow rates, the 100 µm beads did not enter the sampler and consistent sampling 
was observed.  However, the 100 µm beads clogged the detection capillary at 1 µL/min 
pull flow rate and sampling could not be continued without disassembly of the sampler 
(no data point provided).  The 100 µm beads appear to flow into the pull capillary, 
stopping the flow through the system.  The 500 µm bead sample ran without clogging 
while sampling at 4 µL/min, but exhibited flow problems when the system was switched 
to 2 µL/min, which increased with time as the system was switched to a 1 µL/min flow 
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rate (thus the low peak height for 500 µm particles, 50% sample).  The 500 µm beads 
appear to stick to the tip of the pull capillary, causing irregular flow and lower sample 
flow rates.  
 We also investigated the effect of bead concentration on sampling, using 10.0 µm 
beads.  At higher flow rates, consistent sampling between bead concentrations (from 0 
beads/mL to 1x106 beads/mL) was observed.  At a pull flow rate of 1 µL/min, clogging 
was observed for the solution with 1 x 105 beads/mL, resulting in lower sample flow 
(Figure 2-7 B).  While this clog was able to be cleared by reversing the flow through the 
sampler, high concentrations of particles may cause clogging of the sampler and result in 
inaccurate sampling.  To ensure regular sampling, free-floating solid materials should be 




Figure 2-7.  Effect of particles on push-pull sampler.  A. Peak heights at increasing 
flow rates for three bead diameters, as compared to a solution with no beads 













































Particles / mL 
1 µL/min 2 µL/min 4 µL/min 
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 Viscosity.  As pharmaceutical reactions may take place in solutions over a range 
of viscosities (0.2 – 6 Pas is the range of interest, see Table 1-1) we examined the effect 
of viscosity on the ability to sample by sampling blue food color in solutions with 
different viscosities that were adjusted by addition of glycerol.  Viscosity of the solution 
was found to affect the maximal pull flow rate that could be used.  For any solution, a 
threshold pull flow rate exists above which cavitation is observed in the pull syringe, 
resulting in unreliable flow rates.  Above a viscosity of 4.5 Pas, it was not possible to 
sample without cavitation down to the minimal flow rate tested of 1.0 µL/min (Figure 2-8 
A).  This effect imposes a restriction on the system that lower flow rates must be used for 
sampling high viscosity solutions.  The reproducibility of sampling was evaluated at 
viscosities ranging from 1.5 to 4.8 Pas as a function of flow rate.  At a pull flow rate of 
2.0 µL/min, and a push flow rate of 1.0 µL/min, the absorbance readings for 1.5 Pas, 2.6 
Pas and 4.8 Pas viscosity solutions were 3.1 ± 0.2 x 10-3, 3.3 ± 0.2 x 10-3 and 3.2 ± 0.1 
x 10-3, respectively, averaged over 20 injections (Figure 2-8 B).  The constant absorbance 





Figure 2-8.  Effect of sample viscosity on push-pull sampler.  A. Maximum pull flow 
rate achieved before cavitation observed for solutions of a range of viscosities.  B.  
Peak height is not affected by the solution viscosity at pull flow rates less than 
























































 Monitoring an enzymatic reaction with FIA.  The utility of the sampler for 
monitoring reactions that change on a minute time-scale was demonstrated by monitoring 
the turnover of colorless substrate Amplex Red to a highly colored product, resorufin, in 
the presence of horseradish peroxidase and hydrogen peroxide with FIA (Figure 2-9 A).  
The reaction was quenched using Amplex Red Stop Reagent, a proprietary reagent that 
halts the turnover of Amplex Red for 3 hours, according to the manufacturer.  As 
expected, the reaction rate increased with greater concentrations of horseradish 
peroxidase present in the solution.  The push-pull sampler is able to monitor this change, 
with injections of quenched sample to the capillary detector every minute (Figure 2-9 B), 
demonstrating the utility of the sampler for monitoring an enzymatic reaction. 
 This system was also used to verify quenching of the sample solution.  Without 
quenching with Amplex Red Stop Reagent, the Amplex Red substrate continues to turn 
over quickly in the presence of HRP and hydrogen peroxide.  To verify the sample is 
quenched in online push-pull sampling, aliquots of the reaction were removed manually 
while the reaction was running and were quenched manually offline.  The absorbance for 
each offline sample was recorded using an absorbance plate reader.  A plot of offline 
sampling versus online sampling shows that although the absolute value of the 
absorbance is different (different path lengths, different detectors), the two plots may be 




Figure 2-9.  Monitoring an enzymatic reaction with push-pull sampler.  A.  Amplex 
Red substrate turn-over in the presence of horseradish peroxidase (HRP) and 
hydrogen peroxide to form the colored resorufin product.  B.  Resorufin product 
formation monitored after the addition of hydrogen peroxide to a solution of 
Amplex Red and 1, 2 or 4 mU/mL HRP, demonstrate the ability to monitor an 
enzymatic reaction with the push-pull sampler.  C. Overlay plot of reaction 




 Organic reaction monitored by HPLC.  The system was coupled to an HPLC 
system to show on-line monitoring of a reaction with automated separation and detection.  
Base-catalyzed hydrolysis of acetylsalicylic acid (aspirin) results in the production of 
salicylic acid and acetic acid (Figure 2-10 A).  Monopotassium phosphate buffer (10 mM, 
pH 2.3) was used as the quenchant as it changed the pH of the mixed sample to 
approximately 7, stopping the reaction long enough for it to be analyzed with the HPLC.  
The efficacy of the phosphate buffer to halt the turnover of acetylsalicylic acid is 
demonstrated in Figure 2-10 B.  After adding acetylsalicylic acid to the bicarbonate 
buffer, an aliquot was immediately removed, mixed with quenchant offline, and run on 
the HPLC using the autosampler (Figure 2-10 B, 0 min).  This was repeated for the same 
sample after it was allowed to hydrolyze for 15 minutes (Figure 2-10 B, 15 min).  The 
increase in the salicylic acid peak (open circle) can be seen over just 15 minutes.  After 
standing at room temperature for 2 hours, the quenched sample from 0 minutes was run 
again (Figure 2-10 B, 0 min (2 hr)).  Although there is a small increase in the salicylic 
acid peak compared to the initial run, it is considerably less than the product formation 
due to just 15 minutes of hydrolysis.  The phosphate buffer was deemed an acceptable 
quenchant for this reaction. 
 As acetylsalicylic acid was hydrolyzed, sample was collected, quenched, and 
automatically injected onto the HPLC every 5 minutes for 1.5 hours.  For each injection, 
acetylsalicylic acid and salicylic acid were separated within 3.5 minutes, with a decrease 
in acetylsalicylic acid peak area and an increase in salicylic acid peak area over time 
(Figure 2-10 C).  Peak areas, normalized to the initial acetylsalicylic peak are shown for 
three replicate experiments (Figure 2-10 D).  It is believed that the increased standard 
  46 
deviation at the end of the experiment was due to air becoming trapped in one of the 
sample loops for one of the replicates. 
 
 
Figure 2-10.  Monitoring an organic reaction with push-pull sampler.  A. Base-
catalyzed hydrolysis of acetylsalicylic acid to salicylic acid and acetic acid.  B. 
Acetylsalicylic acid sample quenched at 0 minutes hydrolysis and allowed to stand 
for 2 hours has less turnover to salicylic acid than a sample that is allowed to 
hydrolyze for 15 minutes and is immediately quenched and run.  C. Chromatogram 
of aspirin and salicylic acid injected at 0 minutes and 85 minutes following the start 
of the hydrolysis reaction.  D.  Plot of aspirin and salicylic acid peak areas 
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   This experiment demonstrated the utility of the sampler for near real-time 
monitoring of an ongoing reaction.  For each sample, the reaction was halted upon 
removal by a shift in pH caused by the addition of phosphate buffer (pH 2.3) through the 
push capillary, and was automatically analyzed with HPLC.  The reaction progress from 
acetylsalicylic acid to salicylic acid was observed and individual chromatograms could be 
obtained for any given time point, showing a snapshot of the reaction in progress.  
Beyond initial loading of reagents, the entire monitoring process was automated, 
removing the time and potential errors from manual interventions.   
 
Conclusions 
 A push-pull sampling device was demonstrated for monitoring API synthesis.  
The system allowed sampling from solutions with a range of viscosities and automated 
the mixing of quenchant or diluent with sample as part of pre-analysis processing.  The 
system was readily coupled to an on-line detector, flow injection analysis, or HPLC.  The 
device is capable of quenching in 5 s at the sampling site.  Flow properties prevented 
quenchant or diluents from leaking into the reaction vessel and allowed the possibility of 
stopping sampling periodically.  The ability to monitor an ongoing reaction has been 
demonstrated under completely automated conditions.  Computer control of pumps, valve 
and detector through LabVIEW software allow for sampling to be automated.   
 This sampler design fills a need in pharmaceutical PAT for sampling from very 
small-scale reactions (several milliliters).  At the flow rates tested in this work, only 30 
µL of sample is removed for every hour of continuous monitoring.  The system may be 
run at lower flow rates if needed, and the stop-flow feature could be utilized if it was 
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necessary to sample for several days, necessitating the minimization of sample volume 
removal.   
 While this sampler design is promising, it is not suitable for all types of reactions.  
As the sampler is directly in contact with the reaction for long periods of time, the fused 
silica sampling tip would not be suitable for high pH samples.  The fused silica capillary 
is also relatively fragile, which may require the use of coatings or other material to 
improve the robustness of the sampler for daily use in a pharmaceutical setting.  Future 
work will be focused on testing the sampler system with a broad range of reactions, 
particularly with homogenous reactions to further evaluate its utility for pharmaceutical 






SEGMENTED FLOW SAMPLING DEVICE WITH FAST REACTION QUENCHING 
COUPLED TO HPLC FOR PHARMACEUTICAL PAT 
 
Introduction 
 One of the primary challenges in near real-time pharmaceutical sampling is the 
ability to sample from very small-scale research reactions (several milliliters total 
volume).  In this work we present a sampler design that is capable of drawing up a small 
volume of sample (0.1 – 2 µL), mixing each sample with quenchant, and injecting the 
mixed sample into an HPLC.  This system allows for sampling on demand, rather than 
continuously, using less of the reaction volume over a long period of monitoring.  
 Segmented flow uses two or more immiscible fluids in a microfluidic system to 
create small, isolated fluid segments.  In order for the fluid of interest to form a plug, the 
surface tension between the fluid of interest and the other, immiscible fluid must be lower 
than the surface tension between the fluid of interest and the channel wall.79  These 
sample plugs have limited axial dispersion (not able to undergo dispersion beyond the 
length of the plug) and do not interact with previous or subsequent plugs.80  The 
additional of a third immiscible fluid aids in keeping each sample plug separate when 
adding reagents or transporting plugs through tubing.81  When sampling, this allows for 
each plug to be representative of a particular time point, even after multiple 
manipulations (reagent addition, mixing, splitting) downstream.  This was demonstrated 
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with microdialysis sampling from a rat brain for offline analysis with a temporal 
resolution of as little as two seconds.82  Additional information about segmented flow 
may be found in reviews of the topic.79, 83, 84 
 One of the problems with using segmented flow is interfacing the droplets with 
separations methods downstream.  One of the phases may be detrimental to the separation 
process, and it must be removed before analysis may occur.  The effect of fluorinated oil 
continuous phases on and RP-HPLC column has been presented in Appendix A.  While it 
is possible to use a continuous phase that is not detrimental to the separation (such as 
small volumes of air with RP-HPLC), it is often preferable to simply remove the 
continuous phase before the separation step.  One method for separating multiphase flow 
is to press a membrane between two channels, applying pressure to the segmented flow in 
one channel.  The surface properties of the membrane will allow one phase to 
preferentially wet the membrane, passing through to the second channel, while the other 
phase remains in the first channel.  This has been demonstrated to separate hexane and 
perfluorohexane from water, although the separation of hexane and perfluorohexane was 
not achieved with the membranes tested.85  Similar principles were used to separate 
chloroform and water, even in the presence of particulates, using a micro-machined 
polytetrafluoroethylene (PTFE) comb-like structure to preferentially push chloroform 
through the hydrophobic channels, leaving the aqueous phase behind.86  Aqueous 
samples have been separated from a fluorinated oil using derivatized channels on a 
microfluidic chip coupled directly to capillary electrophoresis (CE) separation and on-
chip laser-induced fluorescence detection.87  
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 Segments were produced by aspirating up small volumes of sample or quenchant, 
followed by the continuous phase (a fluorinated oil) using a syringe pump in withdrawing 
mode.  This method is particularly useful when multiple samples are being prepared for 
later analysis downstream.  We were inspired by a paper that used this method,88 along 
with the coalescence properties of segmented flow, to achieve rapid mixing of sample 
and enzymes for reverse transcription polymerase chain reaction (RT-PCR).  We 
developed a sampling method that utilizes the unique properties of segmented flow for 
sampling over time from a set of 5 mL glass vials, with rapid mixing of quenchant to stop 
the reaction for downstream analysis. 
Experimental Section 
 Materials.  Perfluorodecalin (mixture of cis and trans, 95%) and dibutyl phthalate 
(99%) were purchased from Acros Organics (Morristown, NJ, US).  Fluorinert FC-40 and 
1H,1H,2H,2H-perfluoro-1-octanol were purchased from Sigma Aldrich (St. Louis, MO, 
US). Fluorinert FC-770 was obtained from 3M (St. Paul, MN, US).  Red, yellow, green 
and blue food color was sourced from McCormick (Sparks, MD, US).  All water used 
was deionized to 18 MΩ resistivity with an E-pure 1090 series system from Barnstead 
Thermolyne Cooperation (Dubuque, IA, US).  Unless otherwise noted, all other 
chemicals were purchased from Fisher Scientific (Chicago, IL, US). 
 Sampler probe.  The sampler probe consists of a length of narrow-bore (150 µm 
I.D., 360 µm O.D.) perfluroalkoxy (PFA) aspirating capillary (Upchurch Scientific, Oak 
Harbor, WA) inserted into a length of wide-bore (508 µm I.D., 1588 µm O.D.)  PFA 
mixing capillary, secured externally with sticky wax (KerrLab, Orange, CA).  A length of 
narrow-bore PFA transfer capillary was used to connect the other end of the mixing 
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capillary to a syringe on a withdrawing syringe pump (Harvard Instruments, Holliston, 
MA).  The pump may be started and stopped to aspirate a volume of fluid through the tip 
of the aspirating capillary. 
 Sample stage.  The sampler consists of the sampler probe and a sample stage.  
The sample stage tray typically holds a 7 x 4 array of 1 dram glass vials (Fisher), but may 
be used with a 96-well plate or other reactor vessels as well.  The sample tray is mounted 
on an XY-stage in order to select an individual vial/well.  A Z-axis linear actuator is used 
to move the sampler probe up and down to gain access to the vials.  The vials are labeled 
rows A-D and columns 1-7.  For a typical run, a quenchant/diluent is placed in vial A1, 
sample in A2, fluorinated oil in A3, a waste vial in A4 and fluorinated oil in A5.  The 
sampler probe, previously filled with oil, is lowered into the quenchant/diluent, and the 
pump is turned on for a specified amount of time to aspirate a small volume of 
quenchant/diluent (A1) into the aspirating capillary (Figure 3-1 A).  The pump is stopped, 
and the droplet mixer is lifted out of the sample vial.  The sample tray is moved and 
sample (A2) is pulled into the aspirating tip adjacent to the plug of quenchant/diluent 
(Figure 3-1 B).  The droplet mixer is then moved to fluorinated oil (A3).  The 
quenchant/diluent and the sample plugs are pulled sequentially into the wide mixing 
capillary (Figure 3-1 C).   
 The transfer capillary passes through either a variable wavelength detector (for 
direct detection) or an 8-port injection valve for transfer to HPLC.  If using direct 
injection, the droplet is pulled past the detection point for analysis.  When used with 
HPLC, the mixed sample is pulled through an injection loop on a switching valve, 
overfilling the loop.  The valve is actuated and the sample is injected without oil.  Once 
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detection is complete, or sample is injected, the stage is moved to a waste vial (A4) and 
the pump is reversed, clearing the sample from the system.  The stage is finally moved to 
a secondary vial of fluorinated oil (A5) where a small volume is aspirated to ensure the 
sampler is primed for the next sample.  The droplet mixer is mounted on a Z-axis linear 
positioner, allowing the mixer tip to be lowered into the desired sample vial.  A program 
to control the XY-stage, the Z-axis positioner, and starting and stopping the syringe pump 
was created in-house with LabVIEW by Mr. Stephen Parus. 
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Figure 3-1.  Overview of droplet sampling.  Quenchant (Q), sample (S), fluorinated 
oil (O) and waste (W) vials are placed on a movable stage.  A. Small volume of 
quenchant is aspirated into the probe using a withdrawal syringe pump.  B. Small 
volume of sample is aspirated into the probe.  C.  Oil is pulled into the probe and the 
quenchant and sample plugs coalesce, mixing as they travel up the mixing capillary. 
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 Oil/solvent capability.  Glass vials containing 1 mL of each solvent (toluene, 
methanol, water, ethanol, or isopropanol) were placed in sample positions 1 and 2.  A 
fluorinated oil, selected from FC-770, FC-40, or PFD, was placed in a glass vial in 
sample position 3.  The same oil was used to fill the PFA sampler tubing.  To aid 
visibility, one vial of toluene was colored with Disperse Blue 14 while the other was 
colored with Disperse Orange 25.  Water, methanol, ethanol and isopropanol were 
colored in a similar manner with blue food color (BFC) and yellow food color (YFC).  
Aliquots of each solvent (1 µL yellow, 1 µL blue) were drawn up into the PFA capillary 
in turn, followed by 2 µL oil.  All droplets were ejected from the Teflon tubing between 
solvents.  The PFA tubing was rinsed with air and the new oil three times before tests 
were started with new oil. 
 Droplet Coalescence.  Solutions of 0.2 M iron (III) nitrate and 0.6 M potassium 
thiocynate were prepared as sample and quenchant.  The two solutions are pale yellow 
and clear, respectively, but turn deep red upon mixing.  Equal volumes of each reagent 
were pulled into the sampler probe for the time and at the flow rate indicated.  Each point 
was identified as coalescing, not coalescing (droplets remained separate), borderline (3/5 
droplets coalesced) or poor mixing (droplets coalesced, but they did not mix across the 
new droplet).   
 On-line Dilution.  The XYZ stage was set up with water in a glass sample vial in 
sample slot 1.  BFC diluted in water was placed in sample vial 2.  FC-770 was used in 
sample vial 3.  Water and BFC were drawn up in turn (total droplet volume 0.5 µL).  
Each droplet was sampled 6 times and the absorbance data was measured with a variable 
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wavelength detector at 280 nm.  The relative volume of BFC was varied to create a 
calibration curve. 
 Using HPLC to Monitor the Hydrolysis of Dibutyl Phthalate.  To better mimic 
a reaction of interest to the pharmaceutical industry, we monitored the base-catalyzed 
hydrolysis of dibutyl phthalate (DBP) using HPLC.  To determine appropriate separation 
conditions, a mixed solution of hydrolyzed DBP and un-hydrolyzed DBP were mixed as 
a test solution (after quenching with acetic acid).  Separation was performed on a guard 
column (Waters XBridge C18 column, 4.6 x 20 mm, 3.5 µm particles).  Mobile phase A 
was 0.1% TFA in water and mobile phase B was MeOH.  The best separation conditions 
were at 2 µL/min flow rate, with 1 minute @ 25% B and 1.5 min @ 75% B.  With 
column re-equilibration, samples could be injected every 5 minutes.  Samples were 
segmented with FC-770. 
 These conditions were used to analyze the base-catalyzed hydrolysis of dibutyl 
phthalate over a period of 3 hours.  The sample was 2 mL 0.1 g/mL DBP in methanol 
mixed with 1 mL potassium hydroxide solution in methanol.  The quenchant was 0.01 
g/mL acetic acid in methanol (mixed with blue food color to visualize droplets in 
sampler). 2 µL acetic acid quenchant was drawn into the sampler, followed by 0.2 µL 
dibutyl phthalate sample. FC-770 was drawn in after the sample, causing it to mix with 
the quenchant.  The quenched plug was pulled through a 0.5 µL fused silica injection 
loop by syringe pump (Figure 3-2).  When the loop was overfilled with sample, the valve 
was triggered, injecting a portion of the quenched sample onto the column (Waters 
XBridge C18 column, 4.6 x 20 mm, 3.5 µm particles).  While the sample was undergoing 
separation and detection, the syringe pump was reversed, ejecting excess sample to waste 
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and preparing the sampler for the next run.  The sampler is able to perform runs “on 
demand”, although the cycle time for this set of conditions was set to 15 minutes. 
 
Figure 3-2.  Overview of droplet sampler connected to HPLC.  Mixed sample and 
quenchant is pulled through an injection loop on the 8-port valve and is injected 
onto the HPLC when the valve is triggered.   
 
 Improving automation.  The bi-directional syringe pump was replaced with a 
flow selector valve (Valco) connected to syringes at a slow (1 µL/min) pull flow rate (for 
drawing up samples), a fast (4 µL/min) pull flow rate (for quickly moving samples to the 
HPLC), a stopped flow syringe (for moving the sampling probe between vials) and a fast 
(50 µL/min) push flow rate (for clearing samples and oil from the sampler probe).  The 
computer program controlling the system was re-written to control this valve to select the 
appropriate flow rate.  The new system was used to run a calibration curve with 0.067 
g/mL dibutyl phthalate in methanol as the sample and 0.01 g/mL acetic acid in methanol 
as the quenchant.  A volume of dibutyl phthalate was drawn into the sampler probe and 
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mixed with acetic acid for a total droplet volume of 2.2 µL.  These droplets were injected 
onto the HPLC as described previously. 
 
Results and Discussion 
 Sampler probe design.  The original version of the probe used a short (1 cm) 
narrow-bore Teflon PFA capillary inserted within wide-bore Teflon PFA capillary.  The 
capillaries were held in position using super glue.  We determined that the super glue was 
too rigid and bending of the capillaries would release them to be free to move relative to 
each other.  We also determined that if the full probe was dipped into a reaction, the 
solvent could wick between the outside of the narrow capillary and the inside of the wide 
capillary.  This would not typically be a concern with biological solutions, as the super 
glue has been shown in other applications to fill spaces between capillaries and prevent 
wicking of solvents.  When testing the probe with toluene as a solvent, the toluene was 
able to dissolve the super glue and wick between the capillaries.  This necessitated the 
construction of a new probe, which would require several hours to insure the glue is 
sufficiently dry for further use.  Two adjustments were made to the probe to solve this 
problem.  First, the narrow capillary was made at least as long as the deepest part of the 
vessel that it was created to dip into, making sure the interface between capillaries never 
came in contact with the reaction fluid.  Only Teflon PFA (relatively chemically inert) 
could come in contact with the reaction.  The fluorinated oil preferentially coating the 
inside surface of the PFA tubing insured that the reaction did not make contact with the 
interface between capillaries internally.  Second, super glue was no longer used to 
connect the two capillaries.  Capillary wax or sticky wax was used to secure the 
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connection as they could be melted, applied in a small area, cooled, and ready to use in a 
matter of minutes.  The waxes, however, have not been tested for compatibility with any 
of the reactions, so it is recommended that they not come in contact with the reaction 
solvent as it may dissolve the wax, destroying the probe or contaminating the reaction. 
 
 
Figure 3-3.  Visualization of droplet coalescence: Solutions of 0.2 M iron (III) nitrate 
and 0.6 M potassium thiocynate were used to provide a visual indication of droplet 
coalescence.  The iron (III) nitrate  solution is pale yellow and the potassium 
thiocynate solution is clear but upon mixing they rapidly turn a deep red-brown 
color.   
 
 XYZ motion.  A stainless steel stage was originally built to appropriate 
dimensions to hold a standard 96-well plate securely.  Polystyrene plates are commonly 
used for many biological assays, but they are not chemically compatible with many 
organic solvents, such as acetone or toluene.  The stage was adapted to hold 1 dram glass 
vials.  A simple system of cardboard inserts held the vials in a grid pattern, increasing the 
variety of volumes and types of reactions that could be carried out.  The stage could 
easily be adapted to other vessel sizes and shapes if an appropriate adapter was created to 
hold the vessel securely in place on the stage. 
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  The stage was mounted on linear actuators that allowed programmed movement 
in the x and y directions.  This provided random access to any well or vessel by moving 
to the correct x and y coordinates.  The stage design creates the possibility that multiple 
reactions could be sampled from using the same apparatus.  The sampler probe was 
mounted on a third linear actuator, fixed in the x and y directions, but allowed to move up 
and down in the z direction.  To access a particular reaction vessel, the stage was moved 
to the appropriate position so the sampler probe was directly over the vessel opening.  
The sampler probe was lowered in the z direction until it was at the selected height in the 
reaction volume.  This design allows for sampling from any height in the reaction vessel, 
which would be very useful if the reaction contains immiscible liquids and the researcher 
wishes to select from one layer or the other.   
 Reaction Vessels.  Initial testing was performed with 96-well polystyrene plates.  
Our first experiments repeated the work performed by Chabert et al.88  The plates were 
modified by filling each well with 100 µL water and spraying the entire plate with a 
Teflon aerosol spray to change the surface properties of the plate.  Once the coated plate 
was dry, the water would be removed and the plate would be rinsed and dried, leaving the 
bottom section of each well hydrophilic and the top section very hydrophobic. The 
reaction mixture would be placed into the bottom of the previously prepared well, and 
fluorinated oil would be layered on top.  The entire plate would be covered in an aqueous 
wash layer.  The surface tension of the fluorinated oil against the Teflon-modified portion 
of the plate was sufficient to overcome the density difference between the more dense oil 
and the less dense water.  While this was demonstrated to work very well for PCR 
reactions, this method was not suitable for reactions not carried out in an aqueous 
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environment.  Testing the system with alcohols caused the oil and alcohol reaction layer 
to invert.  When the sampling probe was placed at the bottom of the well, oil was 
sampled rather than the alcohol that was floating at the top of the well after inversion.  
We performed tests and demonstrated that the wash layer was not necessary.  This still 
left us with the problem that non-aqueous samples would invert.  After further testing, we 
determined that the oil layer was not necessary.  The small amount of air pulled into the 
sampler did not cause problems with the segments coalescing into each other upon 
entering the wide-bore capillary.  As a result, we abandoned the plate concept and began 
using open glass vials, which were amenable to organic solvents.  These would not be 
suitable for high pH, however. 
 Oil/solvent capability.  We tested whether 1 µL droplets of solvent would 
coalesce within each fluorinated carrier fluid when mixed with the same solvent.  We 
determined that each solvent coalesced with another droplet of the same solvent for all 
three oils (PFD, FC-40, FC-770).  These droplet segments are on the upper end of 
volumes that would be used with this sampler.  It was noted that both toluene and water 
did not mix thoroughly across the full droplet length.  It is likely that for these systems it 
would be better to use smaller total droplet volumes to ensure full mixing across the 
newly-formed droplet. 
 It was observed over the course of all experiments, that selection of an appropriate 
fluorinated oil continuous phase was necessary for good performance.  While methanol 
samples coalesced well using all oils, we found that when we had dibutyl phthalate 
dissolved in methanol as the sample, it would not coalesce well with another droplet 
containing methanol.  Through trial and error, it was determined that FC-770 was the best 
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oil to use for these samples, resulting in coalescence for all droplets.  The use of a 
fluorinated surfactant, such as perfluorooctanol (PFO) may aid in coalescence for other 
samples.  When testing aqueous samples, it was determined that FC-40 with 1% PFO 
gave optimal droplet coalescence.  Using a lower surfactant concentration resulted in 
sample and quenchant droplets that would not coalesce, while using a higher surfactant 
concentration resulted in breakup of mixed droplets as they were pulled along the mixing 
capillary.  Droplet coalescence and breakup are primarily controlled by adjusting surface 
tension between the continuous fluorinated phase and the sample and quenchant droplets.  
As surface tension for all samples may not be known, it may be necessary to test multiple 
oils before finding the best option to monitor a particular reaction. 
 Droplet coalescence.  Iron (III) nitrate and potassium thiocynate were used to test 
a range of flow rates and sample times that could be used for droplet coalescence.  These 
two reagents start as pale yellow and clear solutions, respectively, but result in a deep red 
color upon mixing, resulting in a definitive visual test for determining if a droplet had or 
had not mixed.  After determining the ideal continuous phase composition for the 
aqueous samples (FC-40 with 1% PFO), each reagent was pulled into the sampler for the 
specified time at the specified flow rate.  Each combination of oil and solvent was tested 
five times.  If all five droplets for a particular solvent/oil pair coalesced and mixed, that 
combination of time and flow rate was defined as coalesced.  If the droplets did not 
coalesce at all, that flow rate and time combination was defined as having no 
coalescence.  If at least three of the five droplets coalesced, that combination was defined 
as borderline.  For some higher flow rates and longer sample times, the droplet volume 
was sufficient that while the droplets coalesced, mixing across the droplet was not 
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complete.  Those flow rates and times were defined as incomplete mixing.  The 
combinations of flow rates and times are plotted in Figure 3-4.  Interestingly, there is not 
a minimum volume needed for coalescence.  Small droplet volumes (0.25 µL or less total 
droplet volume), created at low flow rates and low sample times, tended to not coalesce.  
However, the same size droplets, when created at higher flow rates, are able to coalesce.  
It appears the droplet velocity is high enough that it forces contact between the two 
droplets, injecting one reagent droplet into the other and causing very rapid mixing.  The 
upper limit on droplet volume (around 2.7 µL total droplet volume) is important to 
consider, ensuring good mixing across the droplet.  One of the advantages to using 
droplets is the rapid mixing caused by coalescence, but if the droplet is too large, that 
advantage is removed and more active forms of mixing would have to be incorporated 
into the system, adding additional layers of complexity to the sampler probe.  
 
Figure 3-4.  Plot of flow rate and sampling time necessary for coalescence of 
aqueous samples.  Iron (III) nitrate and potassium thiocynate were used as reagents, 
with 1% PFO in FC-40 as the fluorinated continuous phase. 
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 Droplet dilution.  For the sampler to be effective, it must be able to withdraw a 
set volume of sample and mix it thoroughly with quenchant before downstream analysis.  
Dilute blue food color and water were used to demonstrate the linearity of sampling and 
mixing.  Absorbance at 280 nm is shown for each mixed droplet in Figure 3-5.  Each data 
point is n=6 droplets.  The R2 value for a line fit to the points is 0.99614 indicating that 
the sampler probe withdraws and mixes sample in a defined manner.  
 
Figure 3-5.  Linearity of droplet sampling.  Water colored with blue food color 
(BFC) was mixed with plain water for total droplet volume of 0.5 µL.  Mixed droplet 
absorbance was monitored using a variable wavelength detector.  The plot shows 
absorbance for each set of droplets at a particular percentage of BFC in water.  
 
 Using HPLC to Monitor the Hydrolysis of Dibutyl Phthalate.  The hydrolysis 
of dibutyl phthalate to phthalic acid was monitored over a period of 3 hours.  The sampler 
is able to perform runs “on demand”, although the cycle time for this set of conditions 
was set to 15 minutes.  Selected chromatograms are presented in Figure 3-6.  For the run 
marked “BFC”, the sample was replaced with MeOH to determine which peaks (D and a 
small peak at C) are due to the blue food color in the acetic acid quenchant solution.  The 
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run marked “DBP” is 0.667 g/mL dibutyl phthalate in methanol (no potassium 
hydroxide) in order to identify the pure dibutyl phthalate peak before hydrolysis began 
(F). The next three chromatograms are from immediately after addition of potassium 
hydroxide (0 min), and 75 and 165 minutes after the addition of potassium hydroxide.  
After the addition of potassium hydroxide, the dibutyl phthalate peak (F) decreased over 
time, while the hydrolysis peak (B) increased over time, with intermediate half-
hydrolysis peaks (C, E) evident.  The sample was also analyzed with the system after 
reacting overnight (24 hr) to show changes in the chromatogram overnight.  Peak areas 
for over time are plotted in Figure 3-7.   
 
Figure 3-6.  Selected dibutyl phthalate hydrolysis chromatograms as monitored with 
the droplet sampler.  BFC run has blue food color only, showing the contribution to 
peaks C, D.  DBP run has blue food color and dibutyl phthalate, identifying peak F 
as dibutyl phthalate.  The other runs show intermediate peaks.  The product, pthalic 





Figure 3-7. Dibutyl phthalate hydrolysis peak areas as monitored by droplet 
sampler.  Peak A is the product, phthalic acid.  Peak F is the reactant, dibutyl 
phthalate. The other four peaks are intermediates, marked on Figure 3-6. 
 
 Improving automation.  The bi-directional syringe pump was replaced with a 
flow-selection valve to improve automation of the system.  Previously, the syringe pump 
could be stopped and started automatically, but changes in flow rates and pumping 
direction were performed manually.  As there is a finite time required for the pump to 
reverse flow, rather than program the flow using the pump itself, we opted to use a flow-
selecting valve.  The valve was connected to four syringes, each at a different flow rate 
(slow pull, fast pull, fast push, stop).  The flow path for the valve allowed continuous 
flow through the syringes to an oil reservoir to avoid any delay in starting or stopping 
flow.  The desired syringe could be selected automatically, applying that flow rate to the 
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sampler probe.  The droplet sampler software was modified to accommodate these 
automation improvements. 
 The change in the system did improve the automation of the system by 
eliminating the need to manually adjust flow rates during the sampling process.  Efforts 
to fully automate the system were not successful, as the droplets did not move at the same 
flow rate for each injection.  As a result, when overfilling the injection loop, the droplets 
were not properly centered prior to injection, and the portion of the droplet that was 
injected was not reproducible.  Without adjustments by the user, oil, rather than sample, 
could be injected on to the column, necessitating column rinsing before additional 
samples could be run (see Appendix A for more information on fluorinated oils injected 
onto an RP-HPLC column).  Based on observations of gas bubbles forming in the oil 
fluid lines while the droplet is being transferred to the injection loop, it appears that 
compressible gas bubbles are causing the instability in flow rate that leads to 
irreproducible injections of the droplets.  All connections have been checked to eliminate 
air leakage as much as possible.  It is likely that the source of these bubbles is dissolved 
gasses within the fluorinated oil itself.  Using lower pull flow rates can improve the 
reproducibility of droplet flow, but it significantly increases the time needed to transfer 
the droplet to the injection loop.  This is a limitation on the system that will need to be 
solved if the system is to be fully automated.  One possible solution would be to place a 
small sensor on the fluid lines leading into the injection loop to determine when the 
droplet is fully centered within the loop, automatically triggering the injection valve.  
 The automated system was used to run a calibration curve (Figure 3-8 A) to 
compare with a calibration curve run with the bi-directional pump (Figure 3-8 B) and a 
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calibration curve run with smaller droplets without the HPLC (Figure 3-5).  A volume of 
quenchant (0.01 g/mL acetic acid in methanol with added blue food color) was drawn up 
followed by a volume of sample (0.67 g/mL dibutyl phthalate in methanol) for a total 
volume of 2.2 µL.  The droplet was centered on the injection loop and the injection was 
triggered manually.  The quenched dibutyl phthalate sample was separated using a 
gradient as described previously.  Peak area for the DBP peak was calculated with in-
house software.89  The calibration was linear, but RSDs for each point ranged from 1.4-
23.9%, with the highest RSD for the smallest sample volume (Figure 3-8 A). As a 
comparison, the same experiment was run with the previous iteration of the system (bi-
directional pump) using the same flow rates.  Peak area RSDs ranged from 6.2-14.9% for 
this system.  These RSDs are higher than our goal of 5%, and include variation due to 
sampling, injection, and the HPLC itself.  We had postulated that the a primary source of 
variation was due to the stopping and starting of the bi-directional pump, leading to 
variation in the volume of fluid drawn up by the sampler probe; however, if that were the 
case, we would expect to see significant improvement in RSDs when the pump was 
replaced by the flow-selection valve, which is not the case. Smaller droplets that are not 
injected onto the HPLC (Figure 3-5) have much better reproducibility, indicating that 
variability in drawing up samples may not be the major problem.  It appears that part of 
the reproducibility problem may be due to incomplete mixing within the droplet.  Using 
smaller droplets to improve mixing may solve this problem, but smaller droplets are more 
difficult to reproducibly inject using the current injection valve system.  Improvements to 
the injection valve would allow for the system to be fully automated and for smaller 
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droplets to be tested with the HPLC, determining if reproducibility may be improved for 
the system. 
 
Figure 3-8.  Comparison of calibration curves with improved automation.  A. 
Calibration curve run with a flow-selector valve in place to automate flow rates in 
the sampler probe.  B.  Calibration curve run with a bi-directional syringe pump 




 A sampling system was designed to monitor very small (several milliliters) 
reaction volumes.  The sampling probe was constructed from Teflon PFA tubing for high 
chemical resistivity and used the principles of droplet microfluidics to mix sample and 
quenchant before injection onto an HPLC.  A stage for manipulating the sampling probe 
was constructed with automated software, allowing sampling to occur from a variety of 
small reaction vessels.  The sampler has the potential to monitor multiple reactions 
simultaneously, although that capability has not yet been tested. Base-catalyzed 
hydrolysis of dibutyl phthalate was monitored for three hours using the droplet sampling 
system, demonstrating its capabilities for reaction monitoring coupled to HPLC.  While 
the system holds promise, there are concerns with automating the system and improving 
reproducibility.  Future work for this sampler design will be focused on improving 




DEVELOPMENT AND CHARACTERIZATION OF SAMPLING DEVICE FOR 




 The ability to sample from a reaction containing solid particulates is a challenge 
for the pharmaceutical industry.  Particulates may be present in biological samples due to 
cell debris.  They may also be present in organic reactions either due to reactants that 
have precipitated out of the solution, or the presence of solid catalysts.  Representative 
sampling of these reactions is important for understanding the reaction process.  Many 
sampler designs simply avoid the problem by installing filters on sample intake.  Some 
commercial automated samplers are designed to handle particulates and larger sampler 
volumes.  However, these samplers are restrictive in what size and shape of reactor for 
which they may be used. We envision a sampling system that will work with solid 
particulates and can be mounted on a range of reactors, from a 50 mL round-bottom flask 
up to a multi-liter manufacturing-scale reactor.   
 We have developed a prototype sampler that meets these requirements, 
constructed from glass, Teflon, PEEK and stainless steel for compatibility with a wide 
variety of potential reactions.  After evaluating several versions, we have developed a 
prototype that is capable of monitoring a reaction for at least three hours as well as 
handling particulate matter.  We envision further development of this prototype to 
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improve automation and portability with the ultimate goal of a standardized sampling 
system suitable for commercial use. 
 
Experimental Section 
 Materials.  Dibutyl phthalate was sourced from Acros Organics Morristown, NJ, 
US).  Blue food color (water, propylene glycol, FD&C Blue 1, 0.1% propylparaben) was 
obtained from McCormick (Sparks, MD, US).  Polystyrene beads were purchased from 
Polysciences, Inc. (Warrington, PA, US).  All water used was deionized to 18 MΩ 
resistivity with an E-pure 1090 series system from Barnstead Thermolyne Corporation 
(Dubuque, IA, US).  Unless otherwise noted, all other chemicals were purchased from 
Fisher Scientific (Chicago, IL, US). 
 Sampler Body Construction.  The sampler body was constructed in-house from 
glass tubing and a Teflon stopcock (Figure 4-1 A).  The main sampler body is 10 mm 
OD, 1.5 mm wall Kimax borosilicate tubing (Chemglass Life Sciences, Vineland, NJ, 
US) that has been modified to incorporate inlets and outlets.  The top of the sampler is 8 
mm glass thread removed from a Wheaton 2 mL specimen vial (Fisher Scientific).  The 
thread is topped with a twist cap equipped with a Teflon-backed rubber septum (Fisher) 
for syringe access.  Two pieces of 1” long 3 mm OD, 0.2 mm wall Kimax borosilicate 
tubing (Chemglass) were welded on to the sampler body to allow liquid (90° to main 
body) and gas (45° to sampler body) access through the two side arms.  The sampler 
body was welded on to a straight bore stopcock with 1 mm bore Teflon plug (Chemglass) 
to allow sample access.  The stopcock had been altered to allow full drainage of the 
sampler body to the outlet using the transfer position (Figure 4-1 B).  A 1 mm angled 
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hole was drilled to intersect with a 1/8” hole drilled into the side of the stopcock.  Teflon 
PFA tubing (1/8” OD) was pressed inside the side hole to create an outlet for mixed 
sample. 
 
Figure 4-1.  Overview of soup pot sampler construction.  A. The sampler was welded 
together from Kimax borosilicate glass tubing (main body, liquid inlet, gas inlet) 
and a 1 mm bore Teflon stopcock.  Glass threading from a specimen vial was welded 
to the top and a cap with a Teflon-backed rubber septum was added to provide 
sealed syringe access.  B.  The stopcock has three positions: open, closed and 
transfer.  When open (handle is 0° to sampler body), the stopcock allows the syringe 
needle to pass completely through the 1 mm hole to reach into the reactor placed 
below the sampler.  When closed, (handle is 45° to the sampler body) the sampler is 
completely sealed to fluids and the syringe.  When in transfer position (handle is 90° 
to sampler body) fluid is able to flow out of the sampler body and is transferred out 
the side of the stopcock to the outlet. 
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 Sampler System.  The sampler was connected to 1/16” OD x 0.02” ID Teflon 
PFA tubing (Upchurch Scientific, Oak Harbor, WA, US) with 1/8” OD x 0.063” ID 
silicone tubing (New Age Industries, Southampton, PA, US).  The inlet was connected to 
a syringe pump (Harvard Instruments, Holliston, MA, US) with Teflon PFA tubing for 
fluid flow.  Peek unions (Valco) were used to connect syringes to the tubing.  The gas 
inlet was connected to Teflon PFA tubing in the same manner.  An air-filled syringe was 
connected to this tubing to provide pressure for clearing solution from the sampler body.  
A 250 µL syringe connected to a removable 6” long 22 gauge non-coring needle (Fisher 
Scientific) was inserted through the septum in the cap and remained in place during all 
experiments.  The outlet through side of the stopcock was connected to Teflon PFA 
tubing press-fit into the outlet hole.  The outlet tubing was connected to a 250 µm ID tee 
(Valco) with the majority of flow going through another piece of Teflon PFA tubing to a 
waste container.  For any experiments with HPLC, the side arm of the tee had a piece of 
fused silica capillary (250 um ID, 360 um OD) connected through an injection valve to 
vacuum to pull a portion of the outlet fluid for injection.  The 8-port micro-actuated 
injection valve (Valco) was fit with 5 µL fused silica injection loops connected to an 
Agilent 1100 series HPLC (Figure 4-2).   
 Sampler operation.  To start sampling, the stopcock was manually turned to the 
open position, and the syringe was lowered through the stopcock opening into the 
sample.  A 40 µL volume of sample was manually pulled up into the syringe needle, and 
the syringe was withdrawn so the tip of the needle was inside the glass sampler body.  
The stopcock was switched to the closed position, and the syringe plunger was pressed to 
release sample into the sampler body.  At the same time, 400 µL of quenchant was 
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pushed into the sampler body using the syringe pump.  To aid mixing, the syringe tip was 
lowered to just above the stopcock, and the sample was mixed with the quenchant five 
times by withdrawing and releasing the syringe plunger to pull 100 µL of fluid into the 
syringe.  Once the sample was mixed, the syringe needle was lifted to above the liquid 
level, and the stopcock was turned to the transfer position.  The sample, mixed with 
quenchant, was allowed to flow out the side of the stopcock and through the outlet 
tubing.  Pressure was applied to aid flow by depressing the syringe plunger on the gas 
syringe.  Once the sampler was empty, the stopcock was returned to the closed position to 
reseal the sampler body.  Wash fluid (800 µL) was added to the sample body.  The 
syringe plunger was raised and depressed five times to mix the sample.  This process was 
repeated during each wash, rinsing the syringe as well as the sampler body.  The stopcock 
was then turned to the transfer position and the fluid was flushed out in the same manner 
as described previously.  This process was completed for the required number of washes.  
Once washing was complete, the stopcock was returned to the open position to begin 
sampling again. 
 When the sample was analyzed using HPLC, a vacuum pump was used to pull 
mixed sample through the sample capillary and through the injection loops on the 
injection valve.  When the loops were full, the injection valve was triggered to begin the 
HPLC run.  An XBridge C18 column, 4.6 x 20 mm, with 3.5 µm particles (Waters 
Corporation, Millford, MA, US) was installed on the Agilent 1100 system (Agilent 
Technologies, Inc., Santa Clara, CA, US).  Mobile phase A was 0.1% trifluoroacetic acid 
in water and mobile phase B was methanol.  Separation was performed at 2 mL/min 
using a gradient of 1 minute at 25% mobile phase B, 0.5 minute ramp to 75% mobile 
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phase B and 1 minute hold at 75% B.  Effluent absorbance was monitored at 254 nm with 
a Spectra 100 variable wavelength detector (Spectra Physics, Mountain View, CA, US).  
The detector output was recorded with USB-6008 DAQ card combined with in-house 
LabVIEW software (National Instruments, Austin, TX, US). 
 
 
Figure 4-2.  Overview of soup pot sampling system.  A syringe pierced the septum at 
the top of the sampler body and is moved down and up with the stopcock in the 
open position to obtain sample from the reactor.  The liquid inlet is attached to a 
syringe pump, which flows quenchant/wash solution into the sampler body.  The gas 
inlet is attached to an air-filled syringe, which applies pressure when the plunger is 
depressed to aid in evacuating liquids from the sampler body.  The sampler outlet is 
connected to a tee that splits flow between an injection valve and a waste vial.  A 
vacuum pump is used to pull mixed sample through an injection loop.  When the 
loop is full, the valve is actuated to start HPLC analysis. 
 
  77 
 Sampler washing.  Dibutyl phthalate (0.067 g/mL in methanol) was the sample 
and acetic acid (0.01 g/mL in methanol) was used as both the quenchant and wash 
solution.  Sampling was performed as described previously, and the quenched sample 
was analyzed with HPLC. 
 On-line Dilution.  Dibutyl phthalate (0.067 g/mL in methanol) was the sample 
and acetic acid (0.01 g/mL in methanol) was used as both the quenchant and wash 
solution.  Sampling was performed as described previously except sample and quenchant 
volumes were changed.  An aliquot of sample was drawn into the sampler body and 
mixed with the appropriate volume of quenchant for a total fluid volume of 440 µL.  The 
sampler was washed three times between each sample with the acetic acid solution.  The 
quenched sample was analyzed with HPLC.   
 Reaction monitoring with HPLC.  The sampler was used to monitor the 
hydrolysis of dibutyl phthalate every 15 minutes.  The sample was 10 mL dibutyl 
phthalate (0.1 g/mL in methanol) mixed with 5 mL 10 equivalent potassium hydroxide 
solution diluted to 1.5 g/mL in methanol.  The quenchant and wash solution was glacial 
acetic acid diluted to 0.01 g/mL in methanol.  Samples were processed and the sampler 
was rinsed as described previously.  The sampler was washed three times between each 
sample.  The quenched samples were analyzed using HPLC. 
 Bead slurry.  A slurry of 105-125 µm diameter polystyrene beads in dilute 
aqueous blue food color was prepared as the sample.  Water was used as both the model 
quenchant and wash fluid.  Sampling was performed as described previously. 
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Results and Discussion 
 Sampler Design. The primary consideration of this sampler design was the ability 
to sample from solutions that contain suspended particles.  In order to do this, all parts of 
the sampler had to be wide enough to allow particles up to 500 µm (see Table 1-1) to fit 
through all portions of the sampler.  The sampler was designed to be compatible with 
larger sample volumes (10 µL up to 1 mL) that might be obtained from a round-bottom 
flask or from a larger reactor in a manufacturing setting.  The sampler was designed to 
remove an aliquot from a slurry, quench and mix the sample, including any particles 
present, and then analyze the sample, excluding particles from entering the HPLC. 
 Additionally, we wanted to ensure that the materials used for the sampler were 
generally chemically inert and physically robust.  We used glass, Teflon, PEEK and 
stainless steel for these reasons.  The sampler body was crafted out of a glass body fit 
with a Teflon stopcock on the bottom to allow access to a reactor.  The top of the reactor 
is reversibly sealed with a cap equipped with a rubber septum coated with Teflon (to be 
chemically inert).  A syringe with a long needle is used to access samples and deposit 
them in the sampler body.  Two glass access tubes are welded to the top of the sampler to 
allow for the addition of liquids (quenchant, wash fluids) or gases (to provide pressure 
and for drying the sampler).   
 Sampler washing.  The system was tested to determine how many washes were 
required to fully rinse the sampler body between each sample.  An aliquot of dibutyl 
phthalate was quenched and the mixed sample was analyzed with HPLC (Figure 4-3) 
along with the fluid from each subsequent wash.  The dibutyl phthalate peak area from 
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the third wash was determined to be 0.4% of the original sample peak area.  We 




Figure 4-3.  Washing soup pot sampler.  Plot of dibutyl phthalate (DBP) analyzed 
using HPLC after initial quenching and after each wash.  After three washes, the 
DBP peak area is 0.4% of the initial peak area.  Three washes were determined 
sufficient to clean the sampler body between runs. 
 
 Dilution curve.  Varying volumes of dibutyl phthalate were mixed with acetic 
acid to verify linear sampling could be accomplished.  The sampler body was washed 
three times with 800 µL of wash fluid each between samples.  The dibutyl phthalate peak 
areas were linear with respect to sample volume with an R2 value of 0.9969 for the five 
sample volumes (Figure 4-4).  Sampling reproducibility was good, with peak area relative 
standard deviation (RSD, n = 3) of 2.4%, 2.2%, 4.4% and 0.56%, for 20, 40, 60 and 80 



































sampler itself as well as the HPLC.  The RSD for the 0 µL sample was 67%.  As no 
sample was pulled up at this volume, the variation is primarily due to any residual dibutyl 
phthalate that sticks to the syringe needle as it is lowered into the reactor.   
 
Figure 4-4.  Plot illustrating linearity of dibutyl phthalate sampling.  Increasing 
volumes of dibutyl phthalate were mixed with acetic acid quenchant, adjusted for a 
total volume of 440 µL.   R2 for the line was 0.9969.  Relative standard deviation 
(RSD) for 0, 20, 40, 60 and 80 µL samples were 67%, 2.4%, 2.2%, 4.4% and 0.56%, 
respectively, for n = 3 samples at each volume. 
 Reaction monitoring with HPLC.  We tested the ability of the sampler to 
monitor the hydrolysis of dibutyl phthalate every 15 minutes for a total of 3 hours.  As 
this sampler was designed to handle larger volumes than previous samplers (see chapter 2 
and 3) we sampled aliquots of 40 µL, mixed with 400 µL quenchant.  The peak areas for 
the dibutyl phthalate reactant, the phthalic acid product and the intermediate peaks were 
calculated and plotted for each time point (Figure 4-5).  The plots are comparable to the 
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Figure 4-5.  Dibutyl phthalate base-catalyzed hydrolysis monitored with soup pot 
sampler.  Samples were mixed with quenchant every 15 minutes in the sampler body 
and analyzed using HPLC.  Peak A is the product, phthalic acid.  Peak F is the 
reactant, dibutyl phthalate.  Peaks B-E are unidentified intermediates.  A.  
Chromatograms every hour following start of hydrolysis reaction.  B. Peak areas 




Figure 4-6.  Sampling beads with soup pot sampler.  Slurry of 105-125 µm 
polystyrene beads in dilute blue food color was sampled to illustrate the ability of 
sampler to handle solid particles.  A 40 µL aliquot was deposited in the sampler 
body (SAMPLE).  The sample was mixed with 400 µL quenchant and mixed using 
the syringe (QUENCHED).  The effervescent look to the image is due to beads 
suspended in solution.  After the sampler body had been drained, 800 µL of 
quenchant was added and the solution was mixed (WASH 1).  Beads were still 
clearly visible in the solution.  At the second wash, only a few beads were visible in 
the solution and do not show up on the image (WASH 2).  Wash 3 showed no beads 
visible in the solution (image not shown) indicating the sampler is capable of 
clearing particulate matter in the same number of washes necessary to clean 
homogenous samples from the sampler body. 
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 Bead slurry.  Of primary concern was the ability to sample solutions solid 
particulates.  We tested a solution of suspended beads to determine if the beads could 
pass through the sampler and how many washes would be required to remove the solids 
from the sampler.  When working with beads, we operated the system without the HPLC.  
We determined that the sampler is compatible with a bead slurry.  The beads were 
observed in the aliquot of sample pulled into the sampler body as well as in the quenched 
sample (Figure 4-6).  The beads appear to be fully rinsed from the sampler after the third 
wash, indicating that particles in a sample would be removed under the normal course of 
washing.   
 A previous prototype of the sampler had glass tubing welded directly above the 
Teflon stopcock (similar to the inlets).  This design caused about 40 µL of fluid to remain 
in the sampler after fluid was removed through the outlet.  While this fluid could be 
drawn up by the syringe and then ejected from the sampler, it was difficult to fully 
remove all liquid from the sampler.  This design made it particularly difficult to sample 
beads, as it took five washes to remove beads from the sampler body.  The current design 
allows for more complete flushing of the sampler body and more rapid removal of 
particles. 
 While this sampler design is promising, only 105-125 µm polystyrene beads have 
been tested with this sampler design.  It would be informative to test a wider range of 
bead sizes to determine if it will have problems with clogging of the sampler.  Testing 
particles of other shapes and surface chemistry would also need to be included to gain a 
comprehensive understanding of how the sampler handles particulate matter. 
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Conclusions 
 A sampler was constructed out of relatively rugged and chemically inert materials 
for periodic sampling of reactions containing particles.  The sampler prototype was quick 
to produce and could be easily reproduced with the assistance of a scientific glassblower.  
The sampler utility was demonstrated by monitoring the hydrolysis of dibutyl phthalate 
with the sampler coupled to HPLC.  It was determined that only three washes were 
needed between each sample to avoid carryover.  We demonstrated that the peak area of 
dibutyl phthalate is linearly related to the volume of sample drawn into the sampler body, 
indicating that sampling is representative of the bulk solution.  We demonstrated the 
monitoring of a dibutyl phthalate hydrolysis reaction every 15 minutes for 3 hours and 
showed that the peak areas follow the same trend for analysis of this reaction using other 
sampling systems.  We also determined that the sampler is tolerant of 105-125 µm 
polystyrene beads and that they are able to be removed from the system in the same 
number of washes as was necessary to remove the dibutyl phthalate from the sampler 
body. 
 This sampler prototype is promising for larger samples that contain solid particles.  
Further testing needs to be done with other reactions and particles of other sizes, shapes 
and surface functionalities.  Another key improvement for this sampler would be to 
increase the level of automation.  Currently the sample syringe, quenchant/wash syringe 
pump and stopcock are all moved manually.  The HPLC gradient program and the 
computer program to trigger the injection valve and record absorbance must also be 
triggered manually.  We have proposed a design to automate the system and make it more 









 In this dissertation, we have presented three designs for microscale samplers 
coupled to HPLC for use in near real-time monitoring of pharmaceutical reactions.  Two 
sampler designs, the push-pull and droplet samplers, fill a niche for sampling from very 
small (milliliters) reactors.  The push-pull sampler is a continuous sampling system, 
removing low volumes of sample (30 µL per hour of sample under normal conditions) 
from a reactor.  The system has been shown to be tolerant of particulate matter in the 
reactor, although it was not designed to sample the particulates.  This system has been 
fully automated for sampling, mixing with quenchant, injection to the HPLC and data 
collection and has been demonstrated with near real-time monitoring of an organic 
reaction.   Improvements to this sampler are focused on making the system more robust 
by using less fragile materials, to make it more suitable for daily use in a pharmaceutical 
laboratory setting.  The second sampler design, the droplet sampler, has also been used 
for near real-time monitoring of an organic reaction.  This sampler uses a batch design, 
sampling only when necessary to reduce overall reagent consumption.  This sampler has 
the possibility of being used to monitor multiple reactions, but there are currently 
concerns with automating the system and improving reproducibility. 
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 The third sampler design, the soup pot sampler, fills a niche for sampling from 
reactions containing solid particulates, as modeled by a slurry of polystyrene beads.  This 
sampler removes larger volumes of a reaction than the previous two designs, but could be 
scaled down for smaller samples if necessary.  This system has also been used to monitor 
an organic reaction and has been demonstrated with a polystyrene bead slurry.  Future 
work with this sampler will be focused on building a prototype of fully a automated 
system for use in a pharmaceutical testing laboratory. 
 
Push-Pull on a Microfluidic Chip 
  One of the concerns with the push-pull sampler is that the fused silica capillaries 
used for the body of the sampler may be too fragile for regular use in a pharmaceutical 
environment.  Additionally, while all off-the-shelf parts are used for the push-pull 
system, building the sampler requires careful placement of each component, making 
mass-production difficult using its current design.  Creating a push-pull sampler on a 
microfluidic chip would allow for easy mass-production, and the thicker glass used for a 
chip would make the sampler more robust for regular use.  Additionally, smaller channels 
may be produced on-chip, improving mixing for the sampler. 
  A basic chip design for 1:1 quenching, followed by 10:1 dilution of quenched 
sample has been proposed (Figure 5-1).  The entire chip would be 1 cm wide x 4.5 cm 
high x 2.2 mm thick (if made from Borofloat glass).  The etched area is 4 mm x 40 mm 
and the chip is designed to slide into a round-bottom flask neck.  As mixing is due to 
diffusion across the channels, 40 µm channel widths were used in this design for all 
channels other than the main dilution channel which is 100 µm wide.  For modeling 
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purposes, the channel depth is assumed to be 20 µm and the channels are assumed to have 
a rectangular profile, although if this chip were etched in glass, that would not be the 
case.  The serpentine channel design provides sufficient length for mixing in a compact 
footprint. 
 
Figure 5-1.  Illustration of push-pull sampler on a microfluidic chip.  A. Overall chip 
design.  B. Connections would be made through capillaries at the top of the chip.  C.  
Sampling would be performed at the bottom edge of the chip. 
 Connections between the chip and syringe pumps will be made with fused silica 
capillaries. The chip may be etched deeper or drilled to allow capillary access, and the 
capillaries may be sealed to the chip with epoxy.  In the design shown, fluid is pulled out 
of central mixing channel at 11 µL/min while diluent (10 µL/min) and quenchant (0.5 
µL/min) are pumped in continuously.  Sample that has been quenched and diluted may be 
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pulled through injection loops to interface the chip to HPLC in a manner similar to that 
used for the current push-pull sampler design. 
 Sample is pulled into the chip at 0.5 µL/min in this design, but flow rate may be 
adjusted by altering the flow rates at the top of the chip.  Sampling may be performed by 
dipping the chip directly into sample, or a capillary may be attached if longer distance is 
needed, which will increase the time needed to quench reaction.  In this design, a sample 
is mixed with quenchant 1 mm inside the chip edge to be consistent with the non-chip 
push-pull design, using a Y-shape interface for slightly faster mixing than a T-shape.  
Modeling this design shows that the sample mixes with the quenchant in 0.45 s under 
these conditions (assuming square channels). 
 The chip was designed for production out of borosilicate glass, as it is chemically 
resistant, physically strong, and reusable.  However, borosilicate glass is not suitable for 
long-term use in high pH solutions, and requires a clean room and dangerous chemicals 
such as hydrofluoric acid for the etching process.  A likely alternative to borosilicate 
glass in these cases would be poly(methyl methacrylate) (PMMA).  PMMA can be laser-
etched and injection molded for commercial production.  PMMA is not as versatile as 
glass, however, as it is subject to chemical attack by a wide variety of solvents as well as 
concentrated acids and bases.  
 
Automation of the Soup Pot Sampler 
 Future work for the soup pot sampler should be focused on automation.  
Currently, all steps for sampling, mixing and injection are performed manually.  The 
proposed system is shown in Figure 5-2.  The entire system could be contained on a 
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rolling cart, with the HPLC and computer controls on the bottom level.  The cart could be 
placed next to a variety of reactor types.  A detachable unit containing the sampler body 
and syringe for sampling/mixing (5) would be placed on top of the reactor (Figure 5-3).  
Several solvent bottles (orange caps) will be attached to a flow-selector valve.  The 
solvent bottles may contain quenchant (Q), diluent (D), or rinse (R1, R2) solutions as 
needed.  A computer-controlled flow selector valve (2) would be used to select between 
solvent bottles for quenching, dilution, and washing, as needed.  A small-footprint pump 
(3) would be used to drive fluid from the solvent bottles to the detachable sampling unit.  
A solenoid valve (4) may be incorporated to flush excess fluid to waste (W) when 
switching between solutions.  A detachable unit (5) will contain the sampler body and 
syringe housing for placement on top of a reactor.  A small nitrogen gas tank (6) provides 
pressure to drive fluid out of the sample body.  A tee (7) will split the flow from the 
sampler body.  One portion will be pulled through an injection valve (8) using a small-
footprint vacuum pump (9), while the majority of fluid flows to waste (red cap).  The 
injection valve will be actuated, and the quenched sample filling the injection loop will 
be flushed to the HPLC using the HPLC pump. 
 The detachable unit (Figure 5-3) would consist of an outer body with fluid lines 
(liquid inlet, gas inlet, and fluid outlet) entering the sides of the unit (as marked).  The 
sampler body would be mounted into the unit for stability and portability.  Arms for 
moving the syringe up and down (1) into the reactor as well as drawing up precise 
volumes of fluid would be incorporated into the unit.  Linear actuators would be mounted 
to the side of the unit.  The main linear actuator (LA1) would move the entire syringe and 
the second linear actuator (LA2) down and up to access the reactor.  LA2 will operate 
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independently to move the syringe plunger up and down to draw up precise sample 
volumes and for mixing.  These arms would be computer-controlled.  As an alternative, 
the injection syringe unit from a GC instrument could be repurposed.  A computer-
controlled arm for turning the stopcock (2) would be attached to the body of the 
detachable sampler.  Telescoping tripod legs on the bottom of the sampler (3) would 
allow the sampler to access a wide variety of reactor vessels.  The legs can rest on a 
bench to access a small (5 mL) vial, or rest on the top of a round bottom flask (as shown), 
or be mounted above the opening to a larger reactor.  For stability, a bar on the back of 
the unit should be attached to a sturdy bar to ensure the unit does not get overturned 








Figure 5-2.  Top view of proposed automated soup-pot sampler system (not to scale).  
1.  Solvent bottles to hold quenchant (Q), diluent (D), rinse solutions (R1,R2), and 
waste (W).  2.  Flow selector valve for switching between solvent bottles.  3.  Small-
footprint fluidic pump.  4.  Solenoid valve for priming fluid lines.  5.  Detachable 
sampling unit.  6. Small gas cylinder for pressurizing the sampler.  7. Tee for 
splitting flow to injection valve.  8. Injection valve for HPLC.  9. Vacuum pump for 




Figure 5-3.  Detachable unit for automated soup pot sampler (not to scale).  1. 
Linear actuators (LA1, LA2) for moving syringe down and up for sampling and 
moving syringe plunger for mixing.  2. Arm for rotating the Teflon stopcock.  3. 






EFFECT OF INJECTED PERFLUORINATED OILS ON THE HPLC SEPARATION 
OF ACETYLSALICYLIC ACID AND SALICYLIC ACID 
 
Introduction 
 Segmented flow microfluidics is a useful tool for processing small sample 
volumes (nL – µL).  The sample is sequestered into a droplet or plug within a non-
miscible carrier fluid, typically fluorinated oil.  Reagent may be added directly to the 
sample plug, ensuring that all reagents are mixed only where needed, reducing overall 
reagent consumption.  The technique is even more powerful when coupled to a separation 
method for analysis.  The fluorinated oil is typically stripped out of the system before the 
mixed sample is subjected to separation.  While removing oil before injecting samples 
onto a high performance liquid chromatography (HPLC) reversed-phase column is 
possible, maintaining the plugs would allow for very small sample plugs to be injected.  
The injection loop could be filled with the entire sample segment, as well as oil, allowing 
sample segments smaller than the injection loop to be analyzed consistently.  However, 
the effect of fluorinated oils on the separation capabilities of a reverse-phase high 
performance liquid chromatography (RP-HPLC) column has not been previously studied.  
In this work, we tested the effect of four directly injected fluorinated oils to determine 




 Materials.  Acetylsalicylic acid and salicylic acid were obtained from Acros 
Organics (Morristown, NJ, US).  All water used was deionized to 18 MΩ resistivity with 
an E-pure 1090 series system from Barnstead Thermolyne Cooperation (Dubuque, IA, 
US).  Unless otherwise noted, all other chemicals were purchased from Fisher Scientific 
(Chicago, IL, US). 
 Separation Conditions.  A fixed concentration of acetylsalicylic acid (aspirin) 
and salicylic acid was prepared in methanol and diluted into 10 mM monopotassium 
phosphate buffer (pH 2.3).  A C18 column, 4.6 x 100 mm, 3 um particle size (Varian, 
Inc., Palo Alto, CA, US), was installed on an Agilent 1100 HPLC (Agilent Technologies, 
Santa Clara, CA, US) equipped with an autosampler.  Separation occurred under isocratic 
conditions at a flow rate of 1 mL/min, with 70% methanol mixed with 0.1% 
trifluoroacetic acid aqueous solution as the mobile phase. 
 Testing oils on the HPLC column.  A mixture of acetylsalicylic acid and 
salicylic acid (SA solution) was prepared in methanol and diluted in water.  The 
autosampler was used to inject 10 µL volume of either the SA solution or fluorinated oil.  
Absorbance at 254 nm was monitored using a variable wavelength detector for every 
injection of SA solution and the retention time and separation efficiency for each peak 
was calculated using in-house software.89  For experiments with methanol rinsing, the 
column was rinsed for ten minutes with 100% methanol then re-equilibrated at 70% 
methanol after each injection of oil. 
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Results and Discussion 
 Selection of fluorinated oils.  The oils selected for these experiments are 
commonly used in segmented flow microfluidic experiments.  Each is fluorinated, but has 
slightly different chemical structures and physical properties (Table 6-1).  
Perfluorodecalin (PFD) is a perfluorinated cyclic alkane with the highest density and 
viscosity of the oils tested.  Fluorinert FC-40 is a mixture of two fluorinated alkanes, 
while Fluorinert FC-77 is a mixture of a fluorinated straight-chain alkane and fluorinated 
cyclic ether.  Perfluorooctanol (PFO) is typically used as a surfactant in the fluorinated 
continuous phase.  As it would also be injected onto the HPLC column along with the 
rest of the fluorinated oils, we were interested in what role it might play in the separation.  
There are numerous other fluorinated oils available, each with their own set of chemical 
and physical properties that may be selected for optimal performance in the desired 
application.  We sought to select a commonly-used representative from the most-used 
chemical classes to gain the most understanding of the interaction of fluorinated oils with 




















 Perfluorodecalin.  PFD is one of the most commonly used oils in segmented 
flow applications.  Injecting PFD on an RP-HPLC column has a dramatic effect on the 
peak shape and retention time of alternating injections of SA solution (Figure 6-1 A).  
Plotting the separation efficiency indicates that a single injection of PFD does not have a 
dramatic change on the separation efficiency, but with subsequent injections it decreases 
rapidly (Figure 6-1 B).  Rinsing the column for 10 minutes with 100% methanol after 
each injection of PFD yields reproducible peak shape (Figure 6-1 C), retention time, and 
separation efficiency (Figure 6-1 D). 
 
Oil Name Chemical Name Density Viscosity 






1.855 g/mL 4.1 Pas 
FC-77 C8F18 and cyclic C8F16O 
1.789 g/mL 1.3 Pas 
PFO 1H,1H,2H,2H-perfluorooctanol 1.651 g/mL --- 
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Figure A-1.  Perfluorodecalin.  A. Separation of acetylsalicylic acid (aspirin) and 
salicylic acid on an RP-HPLC column after each injection of PFD.  B. Separation 
efficiency decreasing after each injection of PFD.  C.  Separation of acetylsalicylic 
acid and salicylic acid when the column is rinsed with 100% methanol for 10 
minutes after each injection of PFD.  D. Separation efficiency remains constant after 
multiple injections of PFD. 
 Fluorinert FC-40.  FC-40 is a mixture of two amines, and was shown to have a 
more persistent effect on the RP-HPLC column.  Each injection of FC-40 caused a rapid 
degradation of peak shape (Figure 6-2 A), separation efficiency (Figure 6-2 B) and a 
decrease in retention time (Figure 6-2 D).  While a 10 minute rinse with 100% methanol 
improved retention time and peak shape, a rinse sequence with 20 minutes each of 
methanol, isopropanol, hexane, isopropanol and methanol again was required to 
regenerate the peak shape (Figure 6-2 C).  Even with this extensive rinse (100 minutes, 
plus column equilibration time) the peak shape and retention time did not match the 
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initial separation.  FC-40 does not appear to be suitable oil for use with an RP-HPLC 
column, although it is possible that other solvents may remove it from the column.  
 
Figure A-2.  Fluorinert FC-40.  A. Separation of acetylsalicylic acid (aspirin) and 
salicylic acid on an RP-HPLC column after each injection of FC-40.  B. Separation 
efficiency decreasing after each injection of FC-40.  C.  Hexane is required to rinse 
FC-40 from the column.  D. Retention time decreases after each injection of FC-40. 
 Fluorinert FC-77.  FC-77 had a similar effect on the RP-HPLC column as PFD.  
Degradation in peak shape with decreased retention time (Figure 6-3 A) and decreased 
separation efficiency (Figure 6-3 B) were evident after just one injection of FC-77.  
Methanol was effective in rinsing the column, yielding reproducible peak shape and 
retention time (Figure 6-3 C) and steady separation efficiency (Figure 6-3 D).  FC-77, 





Figure A-3.  Fluorinert FC-77.  A. Separation of acetylsalicylic acid (aspirin) and 
salicylic acid on an RP-HPLC column after each injection of FC-77.  B. Separation 
efficiency decreasing after each injection of FC-77.  C.  Separation of acetylsalicylic 
acid and salicylic acid when the column is rinsed with 100% methanol for 10 
minutes after each injection of FC-77.  D. Separation efficiency remains constant 
after multiple injections of FC-77. 
 Perfluorooctanol.  PFO, while not a commonly used as a continuous phase, is 
often incorporated as a surfactant.  Interestingly, PFO did not have any effect on the 
separation.  Even after multiple injections of PFO, the peak shape (Figure 6-4), retention 
time and separation efficiency (data not shown) were not affected.  The effect of PFO on 
the column using a mobile phase with a lower organic concentration was outside the 
scope of this work.  PFO may be a good continuous phase or surfactant for use in this 
particular application, but further testing would need to be performed to determine if it 




Figure A-4.  Perfluorooctanol.  Separations of acetylsalicylic acid and salicylic acid 
were reproducible after multiple injections of PFO. 
 
Conclusions 
 The ability to inject fluorinated continuous phase directly onto an RP-HPLC 
column would enable sample segments smaller than the injection loop to be reproducibly 
analyzed.  This would enable the direct coupling of segmented flow to HPLC without 
requiring removal of the fluorinated phase, incorporating the sample processing 
possibilities of segmented flow with the reliability of HPLC.  We have determined that 
three of the fluorinated oils tested (PFD, FC-40, FC-77) were detrimental to column 
performance under the tested conditions, while PFO did not have an observed effect on 
column performance.  It was also observed that flushing the column with 100% methanol 
was able to reverse the column degradation for PFD and FC-77, while FC-40 required 
hexane to restore column performance.  We believe that the fluorinated oils are coating 
the column surface, reducing the interaction of sample with the stationary phase.  This 
would result in reduced retention times and decreased separation efficiency, both of 
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which are observed.  We have shown that reproducible separations may be achieved with 
fluorinated oil injected onto an RP-HPLC column and the technique holds promise.  
Further testing with other fluorinated oils and common HPLC solvent systems, such as 
acetonitrile/aqueous mixtures, would be needed to determine if this technique would be 







FINITE ELEMENT MODELING OF MICROFLUIDIC CHAMBER FOR 
MONITORING SECRETIONS FROM ADIPOCYTES 
 
Introduction 
 Finite element modeling was used validate experimental measurements 
characterizing a three-layer, resealable microfluidic chip for monitoring fatty acid release 
from adipocytes.  The chip was constructed from two bonded layers, and one detachable 
layer.  The top, detachable layer could be removed to allow a glass coverslip with a layer 
of cultured adipocytes to be placed in the cell chamber (Figure B-2).  The chip was used 
to monitor non-esterified fatty acid (NEFA) secretions from the cultured cells by mixing 
effluent from the cell chamber with NEFA enzyme assay reagents and Amplex Red (10-
acetyl-3,7-dihydroxyphenoxazine), which was turned over to produce a fluorescent 
product, resorufin.  Fluorescence signal from the enzyme assay was detected on-chip.90 
 The chip was characterized experimentally by flowing resorufin, the fluorescent 
product, through the chip inlet and calculating the time needed to observe a 10% to 90% 
change in the concentration at a points downstream from the cell chamber.  Due to the 
space constraints of the chip design, measurements were unable to be obtained directly at 
the outlet of the cell chamber, making it impossible to directly characterize just the cell 
chamber.  Resorufin flow into the cell chamber was modeled to provide a deeper 
understanding of the fluid flow dynamics and validate experimental results.  A similar 
chip with a larger cell chamber for monitoring glycerol release from adipocytes has been 
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modeled previously in a similar manner.91  Two additional cell chamber designs with 
equal volume were modeled to determine if changing the cell chamber geometry would 
have an effect on the assay temporal resolution.  Finally, the release of oleic acid from 
adipocytes within the cell chamber was modeled to gain an understanding of how fatty 
acids were rinsed out of the cell chamber as well as whether fatty acids released upstream 
might be affecting cells located downstream within the cell chamber. 
 
 
Figure B-1.  Microfluidic chip design for monitoring adipocyte fatty acid release.  A. 
Top view of each layer of the chip.  Only the cell chamber was modeled for this 
work.  B. Side view of the chip with the cover slip shown inside the cell chamber.  




 COMSOL Multiphysics 3.5a (Comsol, Inc., Burlington, MA) was used to model 
the flow and concentration of resorufin or oleic acid within the cell chamber.  For the 
standard design, the cell chamber was modeled as a box 12.5 mm long x 2.0 mm wide x 
0.4 mm deep.  On each end of the chamber (2.0 cm x 0.4 mm), rectangular 5 µm tall inlet 
and outlet slits were placed 0.3 mm from the bottom of the cell chamber and spanned the 
full 2.0 mm width of the channel.  The actual chip design (Figure B-1 A) uses a three 
channel weir for the inlets and outlets, but slits were used instead for ease of modeling.  
For the “sideways” cell chamber configuration, the cell chamber was modeled as 2.0 mm 
long x 12.5 mm wide x 0.4 mm deep.  Inlet and outlet slits (5 µm tall) were placed 0.3 
mm from the bottom of the cell chamber and spanned the full 12.5 mm width of the side 
of the chamber.  The “square” cell chamber configuration was modeled as 5.0 mm long x 
5.0 mm wide x 0.4 mm deep.  Inlet and outlet slits (5 µm tall) were placed 0.3 mm from 
the bottom of the cell chamber and spanned the full 5.0 mm width of the chamber.  Both 
alternate configurations had the same total chamber volume and volumetric flow rate as 
the standard cell chamber configuration. 
 Fluid flow was defined as laminar, with a volumetric flow rate of 8 µL/min 
through the cell chamber.  The model used a temperature of 37 °C and diffusion 
constants were adjusted for temperature.  The density of water used was 993 kg/m3 and 
the viscosity of water was 6.90 x 10-4 Pas.  Resorufin flowing into the cell chamber was 
modeled at a concentration of 30 µM, with a diffusion coefficient of 9.01 x 10-10 m2/s.  
The diffusion coefficient for oleic acid was modeled as 5.26 x 10-10 m2/s.92  
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 Oleic acid release from adipocytes was modeled using the standard cell chamber.  
Release from the cells was modeled to occur 31.25 µm above the cover slip to represent 
the radius of a differentiated adipocyte and an average point of release from the cells.  An 
inward flux was selected that resulted in an oleic acid concentration at the outlet that 
matched experimental results. 
  
Results and Discussion 
 Resorufin flow into the standard cell chamber was modeled first.  The 
concentration of resorufin at the center of the outlet slit was monitored over time.  Based 
on the model, the response time (time to change from 10% to 90% of the resorufin 
concentration) was calculated to be 43 s as modeled (date not shown).  The response time 
for the experimental system was calculated to be 41 s based on observing the response 
time before the inlet and after the outlet.  Anna M. Clark calculated the experimental 
values.  The close match between calculated response times for the cell chamber in the 
modeled and experimental systems indicate that the model may be used to gain a valid 
understanding of the flow within the cell chamber. 
 The cell chamber geometry was based on a previous microfluidic chip design91 
which was miniaturized to decrease reagent use and enable a smaller number of cells to 
be studied.  Two other cell geometries were tested to determine if they had better 
response times as modeled and determine if the chip should be altered to use a different 
cell chamber geometry. 
 Side views of each cell chamber design (Figure B-2) shows resorufin flowing into 
the chamber over time.  In all three designs, the lower outlet corner of the cell chamber 
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does not reach the maximum resorufin concentration over time as the fluid is rapidly 
swept up and out of the cell chamber through the outlet.  Although this is a small volume, 
this may have implications for how many cells are actually stimulated to release fatty 
acids when a drug is flowed into the cell chamber and may need to be considered when 
performing cell studies.  
 
Figure B-2.  Flow of resorufin into three cell chamber geometries.  A side view of 
each cell geometry (current, sideways, square) is shown with 30 μM resorufin 
flowing into the chamber inlet (left side) at 8 μL/min at four time points for each 
geometry.  Resorufin concentration across the cell chamber is indicated by 
colormap, with red indicating high resorufin concentration, and dark blue 
indicating a zero resorufin concentration.  In all three geometries, resorufin can be 
seen flowing up and out of the outlet slit (right side), leaving a corner of the cell 
chamber at a lower resorufin concentration. 
 The time necessary to reach 90% resorufin concentration for percentage of cells 
reached was modeled to determine how quickly a drug could stimulate groups of cells as 
it flowed into the system.  The modeled results show that the three cell chamber 
geometries are nearly identical in the time required to flow resorufin over a percentage of 
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cells (Figure B-3).  The square cell chamber has slightly lower times overall, but the 
difference was not considered sufficient to change the cell chamber geometry for future 
experiments. 
 
Figure B-3.  Time required to flow resorufin over cells for three chamber 
geometries.  Times for each chamber geometry were very close, with a slight 
improvement using the square cell chamber model.  The difference in time was not 
considered sufficient to modify the cell chamber geometry for future experiments. 
 Efflux of oleic acid from cells was modeled to determine how rapidly a step 
change in NEFA efflux should be observed at the cell chamber outlet.  A side view of the 
cell chamber (Figure B-3 A) shows that the oleic acid is rapidly flushed out of the 
system, remaining concentrated directly above the cells and not filling the chamber.  The 
image shows a compressed cell chamber length so that the oleic acid concentration could 
be observed.  A plot of the outlet concentration over time (Figure B-4 B) shows a 10% to 
90% response time of 56 s, representing the fastest change in cell efflux that could be 
measured using this system.   
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Figure B-4.  Model of oleic acid release from adipocytes.  A. Side view of standard 
cell chamber showing NEFA concentration distribution following a six-fold step 
increase in NEFA efflux.  B.  Plot showing the simulated NEFA concentration at the 
outlet after a six-fold increase in NEFA efflux.  Arrow indicates start of step change 




 The cell chamber of a microfluidic chip was modeled using COMSOL to provide 
deeper insight into flow within the chamber, as it could not be directly observed due to 
fluidic ports crowding the chip surface.  The cell chamber was first modeled with 
resorufin flowing into the inlet.  The response time at the outlet was calculated to be 41 s 
experimentally, and 43 s using the model, indicating that the model can be used for 
understanding flow within the cell chamber.  Three cell chamber geometries (standard, 
sideways, and square) were modeled and the time required for resorufin to flow over the 
bottom surface of the cell chamber was calculated.  It was determined that the square 
geometry had slightly faster times than the other two geometries, but it was not a 
sufficient improvement to justify changes to the cell chamber design for this set of 
experiments.  Finally, oleic acid release from cells lining the bottom of the cell chamber 
was modeled.  Response time of 56 s at the outlet was calculated for a six-fold increase in 
fatty acid efflux, indicating this is the fastest change in fatty acid efflux that can be 






PUSH-PULL SAMPLER CONSTRUCTION 
 
 
 The following work gives a detailed description of how the push-pull sampler 
probe was constructed.  The push-pull sampler probe consists of a sampling tee, PEEK 
ferrules, a push capillary and a pull capillary (Figure C-1).  Wrenches (1/4”) and 
superglue are required for assembling the sampler.  The push capillary (40 µm ID, 100 
µm OD) was 25 cm long, with a short (~3 cm) piece of capillary (250 µm ID, 360 µm 
OD) attached with super glue at one end to facilitate connection to the push syringe using 
a union.  The wider capillary was placed on the end of the push capillary, and a drop of 
superglue was placed on the end of the wider capillary, away from the end of the push 
capillary.  The super glue was allowed to wick between the two capillaries, and was 
allowed to dry overnight.  The pull capillary (250 µm ID, 350 µm OD) was 5 cm long.  
The sampling end (shown on left) had the polyimide coating burned off to facilitate 
alignment of the push and pull capillaries.  The stainless sampling tee (Valco MT1XCS6) 
was 150 µm bore, and breaks apart into an insert, outer stainless ring and three nuts, as 
shown.  A Valco FS1.2PK ferrule was used to connect the push capillary and two Valco 
FS1.4PK (2) used to connect the pull and transfer (not shown) capillaries. 
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Figure C-1.  Materials needed to construct the push-pull sampler probe. 
 To assemble the sampler, the sample tee and insert (Figure C-2, 1) holes were 
aligned and the insert was placed inside the tee (Figure C-2, 2).  The push capillary 
(narrow end) was threaded through a nut, the FS1.2PK ferrule and completely through 
the main portion of the tee (Figure C-2, 3).  Once the capillary was through the tee, the 
nut and ferrule were placed into the tee, but not tightened so the push capillary was free 
to slide through the tee (Figure C-2, 4).  The pull capillary was threaded through a nut 
and one of the FS1.4PK ferrules.  Note that the clear tip with polyimide removed was 
facing away from the tee (Figure C-2, 5). 
 
Figure C-2.  Steps to assemble the push-pull sampler probe, part 1. 
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 While holding the tee and push capillary in one hand and the pull capillary 
assembly in the other hand, the push capillary was threaded into the pull capillary (Figure 
C-3, 6) and completely through, until the push capillary was visible on the other side of 
the pull capillary.  The pull capillary was secured inside the tee by tightening the nut 
down on the ferrule (Figure C-3, 7).  The push capillary was securely attached to the tee, 
with the clear tip facing away from the tee, while the push capillary remained free to 
move.  The push capillary was aligned so the tip of the capillary was recessed 1 mm 
inside the tip of the pull capillary (this was performed under a microscope).  The push 
capillary was secured by tightening the nut to clamp down on the ferrule holding the push 
capillary in place (Figure C-3, 7). 
 
Figure C-3.  Steps to assemble the push-pull sampler probe, part 2. 
 The probe was connected to the rest of the push-pull sampler system through a 
transfer capillary.  The transfer capillary (150 µm ID, 360 µm OD) was connected to the 
side arm of the tee using a nut and a FS1.4PK ferrule (Figure C-4, 9).  The nut was 
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tightened down to ensure air did not leak into the system.  The push capillary was 
connected to a syringe using a stainless steel union (Valco) and FS1.4PK ferrules (Figure 
C-4, 10).  The push capillary was flushed with the quenchant fluid (Figure C-4, 11).  If 
the sampler probe was constructed properly, fluid should be observed at the tip of the pull 
capillary.  The sampler probe was placed in a vial of liquid while all capillaries were 
primed to ensure no air was in the system (Figure C-4, 12).  The push capillary was 
connected to a syringe pump, while the transfer capillary was connected to an injection 
valve (for FIA or HPLC monitoring) which was in turn connected to a withdrawing 
syringe pump (Figure C-4, 13).  The rest of the system was constructed as described in 
Chapter 2. 
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